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ABSTRACT OF THE DISSERTATION
Investigating the Role of Bladder Epithelial Stem Cells in Bladder Mucosal Remodeling and
Defense Against Infection
by
Seongmi Kim Russell
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Microbiology and Microbial Pathogenesis
Washington University in St. Louis, 2021
Professor Scott J. Hultgren, Chair

Urinary tract infections (UTIs) can be highly recurrent, and the mechanism(s) governing
recurrence susceptibility are mostly unknown. Here I demonstrate bladder epithelial (urothelial)intrinsic trained immunity as part of a differential mucosal remodeling response to an initial UTI.
I established urothelial stem cell (USC) lines from isogenic mice with different UTI histories
(naïve, chronic, or self-resolving) and discovered 2880 differential genome-accessible
regions, indicating differential epigenetic reprogramming dependent on infection history.
Differentiation of USC lines in vitro resulted in polarized urothelial cultures that recapitulated
distinct remodeling morphologies seen in vivo and exhibited altered gene expression, including
genes involved in cell death pathways. Our work may in part explain the clinical observation that
a history of prior UTI is a risk factor for recurrent UTI and may lead to novel therapeutic strategies.

ix

Chapter 1: Introduction
1.1 Urinary tract infection
1.1.1 Urinary tract infection: clinical symptoms and challenges
Urinary tract infection (UTI) is one of the most common bacterial infections worldwide and is a
significant cause of morbidity in otherwise healthy females, with an estimated 60% lifetime risk
(1, 2). While UTI is significantly more prevalent in women, it is also seen in infant boys and older
men (3). Uropathogenic Escherichia coli (UPEC) are responsible for approximately 85% of
community-acquired UTIs and 50% of nosocomial UTIs (4, 5).
Symptomatic UTIs are diagnosed by the presence of bacteria in the urine (bacteriuria) and
can present as either cystitis (infection of the bladder) or as pyelonephritis (infection of the kidney
or upper urinary tract). In women, the most common outcome of UTI is cystitis while
pyelonephritis rarely occurs in the absence of other host susceptibility factors (6, 7). The
pathogenesis of cystitis begins with colonization of the vaginal introitus by uropathogens from the
fecal flora, followed by ascension via the urethra into the bladder, eventually leading to clinical
symptoms of cystitis which include frequent urination, pain or burning sensation with urination
(dysuria), cloudy, bloody, or strong-smelling urine, and lower abdominal discomfort. UTI can also
be asymptomatic. Asymptomatic bacteriuria (ASB) is common in young women and is defined as
high levels of bacteriuria without typical clinical symptoms of UTI such as dysuria or lower
abdominal pain (8). Infection outcomes and patient susceptibility to UTI are determined not only
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by uropathogen virulence factors (9) but also by host factors such as personal and family history
of UTI, structural abnormalities, behavioral risk factors, and genetics (8, 10-12).
One of the major challenges of this disease is the significant risk of developing recurrent
UTI (rUTI), which often presents as clustered infections in the year following the initial UTI
despite appropriate antibiotic therapy (10). 20-30% of women with an initial UTI will experience
a recurrence within 6 months (13), accounting for 10.5 million outpatient and ambulatory care
visits per year in the United States alone (14). Even with antibiotic treatment, some women are
subject to recurrent chronic cystitis (13, 15, 16). Unfortunately, daily antibiotic prophylaxis is
increasingly required to prevent UTI recurrence (17), contributing to the high financial burden of
UTI and the worldwide emergence of multidrug resistant uropathogens (13, 14, 18, 19). Therefore,
further studies to understand the molecular mechanisms underlying UTI recurrence could lead to
the development of novel therapeutics against rUTI.

1.1.2 Pathogenesis of UTI: acute, chronic, latent, and recurrent UTI
Once cystitis-causing UPEC strains such as UTI89 invade superficial facet cells of the
bladder, these strains are able to form clonal, biofilm-like intracellular bacterial communities
(IBCs) (20, 21). The generation of IBCs also depends on other factors such as autoaggregative
factor Ag43, UPEC polysaccharide capsule, and sialic acid (22). Because IBCs replicate within an
intracellular niche, they are protected from components of the host immune response, including
professional phagocytic cells and antibiotic peptides. Thus, the acute pathogenic cascade may
contribute to bacterial resistance to antibiotic therapies (23). In addition, IBC formation facilitates
an efficient spread of bacteria as cells fluxed out of the superficial facet cells reenter the IBC
generation cascade (24, 25), often as long filamentous bacteria extending to surrounding epithelial
2

cells to initiate subsequent invasion, especially in the late stages of IBC formation (26). IBCs have
been experimentally identified in mice bladder and have also been observed in urine and voided
urothelial cells from human patients (24, 27).
Depending on various risk factors, infection outcomes in women can be one of the
following: self-limiting acute cystitis, chronic cystitis, latent infection, or recurrent UTI (13). In
previous placebo-controlled studies, about half of the women developed persistent high
baceteriuria several weeks after an episode of acute cystitis (28, 29). UTI can also remain latent
due to dormant UPEC strains in the bladder cells. Once UPEC have gained access to deeper tissues
during exfoliation, they can invade immature intermediate epithelial cells as well as mature
superficial bladder cells, leading to the establishment of quiescent intracellular reservoirs (QIRs)
containing small number of bacteria, such as pairs and quadruplets (Fig. 1) (30). QIRs are late
endosome-like compartments expressing the late endosomal marker Lamp1. These bacterial
reservoirs have limited replicative capacity and are mostly quiescent, possessing long-term
persistency up to 12 weeks without triggering a host inflammatory response or epithelial
exfoliation (24, 30). Naturally, as intermediate epithelial cells differentiate and migrate towards
the apical surface of the epithelium, persistent reservoir bacteria may emerge and cause recurrent
UTI (31, 32).

1.1.3 Recurrent UTI may be caused by a persistent bladder reservoir or
distal reservoirs
Most women will develop a UTI at some point in their lives, and many will have occasional
recurrences. The pathogenic bacteria are usually introduced into the urinary bladder from fecal
reservoirs via periurethral/vaginal colonization, often as a result of sexual activity. Although the
gastrointestinal tract (GIT) microbiota is generally symbiotic and beneficial to the host, imbalances
3

between the host and commensal bacteria may allow opportunistic pathogens such as E. coli to
expand and dominate certain intestinal niches, leading to disease in the GIT as well as at distal
sites such as the urinary tract (33, 34). GIT reservoir strains are shed in the feces, and these bacteria
are easily transferred to the periurethral regions leading to inoculation of the urinary tract.
Some individuals develop recurrent cystitis despite appropriate antibiotic treatment for the
previous infection. Recurrence is categorized as either reinfection or relapse (due to treatment
failure) (35). Reinfection occurs several weeks after antibiotic treatment has cleared the primary
infection and can be caused by the same UPEC strains that caused the initial infection or by
different strains. Reinfection accounts for approximately 80% of recurring infections (36). The
emergence of UPEC in the urinary tract is primarily initiated by the GIT reservoir. However,
subsequent rUTI can be newly seeded from GIT, vaginal, or periurethral reservoirs, or from the
same bacteria fluxing out of QIRs (25, 31, 32). Relapse is characterized by a recurring infection
mediated by the same bacteria, which is often drug resistant. It is diagnosed when a UTI recurs
within three weeks of antibiotic treatment and is due to a failure to eradicate the initial infection
(35).

1.1.4 Host risk factors for chronic cystitis and recurrent UTI
rUTI is defined as three recurrences of UTI in the previous 12 months or two episodes in the
previous six months (37). Some susceptible individuals may have six or more episodes in the year
following an initial UTI (38, 39). However, the mechanism leading to susceptibility towards rUTI
is poorly understood and requires further studies to develop more effective therapeutic strategies
other than daily antibiotic prophylaxis (17). Women generally have higher risk of UTI than men
due to the anatomy of the female urethra, which allows bacteria to easily ascend the urinary tract
(37). Three main host risk factors for symptomatic rUTI in sexually active women are bacterial
4

exposure, a prior history of UTI, and host genetic variation (8, 40). The strongest risk factor is
sexual behaviors; frequent or recent sexual intercourse correlates with the development of UTI in
young women, as physical modulation introduces bacteria into the urinary tract (8, 40). However,
recommending patients to reduce sexual activity to avoid future infection is likely not the best
clinical management. Therefore, it is imperative to find other host-directed therapeutic targets to
prevent or eliminate recurrent UTI in women. Another strong risk factor for rUTI is a history of
prior UTIs, such that a woman who has had a prior UTI is significantly more likely to develop
another UTI than a woman who has never had a UTI (2, 11).

1.1.5 Bacterial risk factors for UTI and susceptibility to rUTI
UPEC strains, which are responsible for more than 80% of all UTI, express diverse
combinations of different virulence factors including fimbrial and afimbrial adhesins, toxins, and
iron-acquisition systems (9, 41) to successfully colonize the host urinary tract and promote UTI.
Type 1 fimbriae, expressing FimH adhesins, are one of the best-characterized UPEC chaperoneusher fimbriae, and bind mannosylated glycoproteins such as uroplakins on the surface of human
and murine bladder cells (41, 42). The interaction between type 1 fimbriae and host surface
receptors promotes bacterial colonization, host cell invasion, biofilm formation, and formation of
IBCs (43). This interaction is enhanced through the formation of catch bonds, mechanical forces
that induce structural alterations in FimH linked to a high-affinity conformation (44).
UPEC also secretes a number of toxins that facilitate its pathogenesis by damaging or
killing host epithelial cells. Secreted toxins, including α-hemolysin and cytotoxic necrotizing
factor 1 (CNF1), can alter host signaling pathways, modulate inflammatory responses, and
stimulate host cell lysis, thus releasing nutrients such as iron and allowing UPEC to access deeper
5

tissues where it may develop long-lived intracellular reservoirs (45-47). However, overexpression
of α-hemolysin induces caspase-1/caspase-4 dependent inflammatory cell death in human
urothelial cells leading to massive exfoliation and rapid clearance of bacterial infection, which was
protective against UPEC infection (48).

1.1.6 The bladder mucosal defense against bacterial infection
The bladder mucosal defense mechanisms consist of physical barriers, innate immunity, and
adaptive immunity. These defense mechanisms are critical for the clearance of UPEC infection
but may also predispose to subsequent chronic cystitis and incidence of rUTI (3). The urinary tract
is lined by a specialized stratified epithelium called the urothelium, which includes mature
superficial facet cells, intermediate cells, and underlying basal stem cells. The superficial facet cell
acts as a physical barrier to bacterial adherence and invasion and also expresses mucins on the
apical surface (49, 50). Upon bacterial adhesion, the outer layers of the urothelium undergo cell
death and rapidly shed infected cells into the urine (urothelial exfoliation). The epithelium then
proliferates and differentiates newly matured superficial cells (51, 52). The underlying urothelial
cells could become hyperproliferative when infection lasts longer.
Upon bacterial infection, an array of pro-inflammatory cytokines and chemokines are
upregulated in urothelial cells, which are mediated by pathogen recognition receptors (PRRs)
interacting with bacterial factors. The primary PRRs responsible for recognizing bacteria in the
urinary tract are TLR4 and TLR5 in humans, as well as TLR11 in mice (53). TLR4 knockout mice
infected with UPEC appear to have high titer bacteriuria with chronic bacterial colonization,
indicating that TLR4 is important for bacterial clearance and the inflammatory response in the
bladder and kidney (52). TLR4 signaling can be mediated by multiple mechanisms including a P
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fimbriae dependent pathway (53, 54), and lipopolysaccharide (LPS) dependent and type 1 fimbriae
dependent pathways (55). Mice with defective TRIF and TRAM adaptors show impaired innate
immune response, while mice lacking MyD88 have a strong innate response to P fimbriated UPEC
similar to wild type mice, suggesting that P fimbriae mediated TLR4 signaling signals through the
TRIF/TRAM dependent pathway (53). In addition, FimH-containing type 1 fimbriae can directly
interact with TLR4 (52). TLR5 recognizes other bacterial virulence factors and signals through the
MyD88 dependent pathway as well (56). These two signaling pathways lead to the activation of
nuclear factor NFkB and subsequent expression of proinflammatory genes, such as IL6, IL8, and
tumor necrosis factor-alpha (TNFα).
Neutrophils are the most rapid and robust responders to bacterial infection in the bladder,
and their recruitment and infiltration to the site of inflammation are mediated by proinflammatory
chemokines including CXCL1 and IL8. Along with neutrophils, macrophages are also important
for innate immunity against bacterial infection as effectors and regulators. Tissue resident Ly6Cmacrophages act as sentinels; they sense bacterial infection rapidly and recruit circulating
neutrophils and inflammatory macrophages through cytokine expression. On the other hand,
inflammatory Ly6C+ macrophages are regulators as they induce resident macrophage to produce
CXCL2, leading to the secretion of matrix metalloproteinase 9 (MMP-9) from neutrophils and
allowing subsequent epithelial transmigration (57). Recently, it has been demonstrated in both
human and mice that exacerbated neutrophil transmigration mediated by upregulated
inflammatory cytokines during UTI results in severe persistent immunopathology and subsequent
rUTI (3). Therefore, serum biomarkers such as IL6, CXCL1, and G-CSF during initial UTI may
predict a predisposition of chronic cystitis and subsequent rUTI (58).
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1.2 Bladder remodeling upon UTI and altered rUTI
susceptibility
1.2.1 Murine model of rUTI
Murine models of UPEC infection in juvenile naïve mice have elucidated critical details of the
pathogenesis of acute UTI in different inbred mouse strains (21, 59). Although environmental,
behavioral and anatomical differences between mice and humans pose a limitation on direct
comparison between human and mouse studies, many studies with murine models have drastically
increased our understanding of UPEC pathogenesis in the mammalian host including the invasion
of UPEC into bladder epithelial cells (21). However, the immunopathology of chronic infection
that predisposes patients to rUTI is difficult to study in naïve mice with pristine bladders (60).
Naïve C57BL/6 mice are relatively resistant to acute cystitis, typically resolving acute infection
and bacteriuria within 7-10 days, and becoming more resistant to secondary challenge infections
(32, 61), making this model inadequate for studying symptoms of rUTI.
Recent studies have found that UPEC infection in C3H/HeN and closely related mouse
strains ends up with two distinct disease outcomes; resolution of acute infection with sterilization
of the urine within days of acute infection or persistent high titer bacteriuria with chronic bladder
bacterial colonization and inflammation (chronic cystitis) that lasts over the entire lifetime if not
treated with appropriate antibiotics (58, 62, 63). Unlike “resolved” mice that are resistant to
challenge infection, age-matched naïve mice with a history of persistent infection become
“sensitized” to rUTI upon a second bacterial challenge four weeks after antibiotic therapy,
emphasizing the clinical relevance of this rUTI model (Fig. 2). This sensitivity can last for the
lifetime of the mice, which indicates that the bladder mucosa has been remodeled in a manner that
alters the pathophysiology of infection over a long-term period.
8

1.2.2 Bladder tissue remodeling subsequent to persistent UPEC infection
predisposes future rUTI
Bladder tissue remodeling may encompass changes to the mucosa ranging from longlasting structural changes such as tissue fibrosis and lymphonodular hyperplasia to epigenetic
changes in gene expression within specific cell types, thus significantly altering host susceptibility
to infection or irritants (64). Signs of bladder remodeling, such as lymphonodular and urothelial
hyperplasia with defects in terminal differentiation, have been documented in patients as well,
including women with highly recurrent UTI, women given placebo in clinical trials for treatment
of acute UTI, and girls with chronic asymptomatic bacteriuria (28, 60, 62). Interestingly, we see
similar lymphonodular hyperplasia by histology in convalescent Sensitized mice that suffered prior
infection lasting 28 days (58). However, we saw no signs of tissue fibrosis by Masson’s trichrome
staining, which indicates infected bladder tissue remodeling is very different from the allergic
remodeling observed in the respiratory tract.
Other evidence of epithelial remodeling upon chronic cystitis includes elevated cytokine
levels, differential gene expression, and altered morphology of epithelial cells in sensitized mouse
bladders and patients with chronic cystitis (3, 15, 40, 58). Elevated serum and urine cytokine
biomarkers such as IL-6, G-CSF and CXCL1 in naïve C3H/HeN mice at 24 hpi are predictive of
the development of chronic cystitis as well as subsequent rUTI. This recapitulates an earlier
epidemiological study, which showed that elevation of serum cytokines IL-8, M-CSF, and CXCL1
correlates with subsequent rUTI (3, 15). Thus, imbalanced severe acute inflammation at the hostpathogen checkpoint, as early as 24 hpi, predisposes to chronic infection and susceptibility to rUTI
(21, 58). The elevation of these cytokines is also observed during secondary challenge infection.
Proteomic and microarray analysis of bladder epithelial cells isolated from sensitized mice during
9

the convalescence period following initial infection and antibiotic treatment further supports the
concept of bladder epithelial remodeling upon chronic cystitis (Fig. 2) (40, 58).
Proteomic differences are mostly related to innate immunity, mucosal wounding, and
inflammation that lead to enhanced sensitivity to oxidative stress from neutrophil damage. For
example, elevated pigR is related to mucosal wound healing. Vanin-1, a surface expressed enzyme
that catalyzes the synthesis of mucosal inflammation inducers during oxidative stress, was
significantly increased in sensitized mice. A number of serpins, serine protease inhibitors that
protects the epithelium from neutrophilic damage, was down regulated in sensitized mouse
bladders. In addition, scanning electron microscopy and fluorescent microscopy have shown
morphological differences in the bladder epithelium as a consequence of immunopathology in both
mice and humans, including smaller and immature superficial facet cells of sensitized mice (48).
These morphological alterations are supported by microarray analysis that demonstrated
downregulation of uroplakins, the terminal differentiation marker in sensitized mouse bladder (40).
Cyclooxygenase-2 (COX-2)-dependent inflammation has been suggested as the most
likely trigger for Naïve mice to develop severe acute and chronic UTI and for Sensitized mice to
develop rUTI (3). Prostaglandins, thromboxanes, and leukotrienes are lipid-derived molecules
collectively known as eicosanoids and are thought to act locally on target cells close to their site
of formation. Two cyclooxygenase enzyme isoforms, COX-1 and COX-2, utilize the substrate
arachidonic acid to catalyze the rate-limiting step of prostanoids (prostaglandins and
thromboxanes) synthesis. Both COX-1 and COX-2 are expressed in the bladder. COX-1, which is
expressed constitutively within the basal and intermediate layers of the urothelium (65), is the
dominant source of prostanoids required for housekeeping functions. COX-2, which is induced by
inflammatory stimuli, hormones, and other growth factors within the basal epithelium, is important
10

for prostanoid formation during inflammation and in proliferative diseases such as bladder cancer
(66). The induced expression of COX-2 gene, Ptgs2, participates in the modulation of
inflammatory responses following bacterial infection. However, the upregulation of Ptgs2
expression is also known to cause bladder mucosal wounding and prolonged acute UPEC infection
by inducing severe neutrophilic inflammation (58, 67). Furthermore, it has been shown that COX2-dependent bladder inflammation triggers Sensitized mice to develop rUTI upon a challenge
infection (68).

1.2.3 History of UTI alters acute bladder inflammation kinetics during rUTI
Using mouse model of rUTI, we found that a prior UPEC infection rewires the bladder immune
response, altering the pathophysiology of a subsequent UTI relative to Naïve mice (68, 69),
including heightened early acute inflammatory response during the first 6-12 hours of infection,
intracellular colonization resistance, and replication in the form of IBCs. Both Resolved and
Sensitized mice resulted in an earlier onset of TNFα-mediated bladder inflammation upon
subsequent challenge infection relative to Naïve mice. In addition, the dynamics of Ptgs2 (COX2) expression mirrored the kinetics of TNFα expression regardless of infection history, suggesting
that TNFα signaling and COX-2 signaling may be associated during bladder infection. However,
the dynamics of TNFα signaling over time differed between Resolved and Sensitized mice. TNFαmediated acute inflammation in Resolved mice peaked early and resolved by 24 hpi, whereas
inflammation in Sensitized mice also increased early, but was sustained through 24 hpi (69). TNFα
depletion studies revealed that transient early-phase TNFα signaling in Resolved mice promoted
clearance of bacteria via rapid recruitment of neutrophils and exfoliation of infected bladder cells,
effectively resolving the infection. In contrast, IBCs were unable to form in Sensitized mice
independent of TNFα signaling. Instead, sustained TNFα signaling and COX-2 dependent
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inflammation in Sensitized mice appear to promote extracellular colonization of severely inflamed
and wounded bladder mucosa allowing them to overcome intracellular colonization resistance (68,
69).

1.3 Research aim and significance
Bladder remodeling in mice with a history of chronic cystitis lasts greater than six months (70).
Therefore, I hypothesized that bladder epithelial stem cells play an important role in the
remodeling phenotype as well as in bladder sensitization. In order to investigate the contribution
of epithelial stem cells, i) I will first establish a culture system for primary bladder epithelial cells
originating from mice with a history of infection and ii) investigate epigenetic modifications of
bladder epithelial stem cells using this primary cell culture system.
The study of bladder epithelial pathobiology has been made feasible through the use of
various experimental models including genetically and microbiologically defined animal models
as well as immortalized epithelial cell lines for in vitro studies (40, 71). Tumor and immortalized
cell lines have been widely used to model physiologic epithelial responses in vitro due to their
simplicity. Studies using these cell lines have provided initial insights into epithelial biology in
many areas. However, their well-known limitations, including the presence of numerous undefined
DNA mutations, altered differentiation status, and altered cell biology, make it challenging to use
these models to study the host immune response against infection or how genetic variations affect
this response. For example, tumor cell culture on a permeable Transwell membrane often provides
a monolayer lacking proper innate immune response against bacterial infections and an
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inappropriate surface localization of urothelial differentiation markers such as cytokeratins and
uroplakin proteins.
Mouse models have shown that UPEC invade terminally differentiated superficial facet
cells upon binding to these receptors (30). As discussed previously, bacterial invasion and IBC
formation in superficial facet cells are critical for UPEC pathogenesis by providing a survival
advantage to persist within the bladder (24, 25). Thus, terminally differentiated superficial facet
cells and proper differentiation states of the urothelium are important factors for investigating
urothelial-UPEC interactions in vitro. Primary bladder epithelial cells can be cultured on a
Transwell membrane to overcome these limitations as they form multilayers with apical-basal
polarity which can be exposed to different factors in the apical and basolateral compartments in a
physiologically relevant manner. Thus, this technique provides the means to study many epithelial
cell processes including interactions with microbes, interactions with immune cells, drug
absorption, and intracellular migration (71, 72). However, it has been cumbersome for the
Transwell system to recapitulate the in vivo maturation of the urothelium due to lack of an efficient
method to propagate primary epithelial stem cells in vitro. Recently, an advanced 3D culture
method by which stem cells were grown as spheroids within a matrigel basement membrane-like
matrix has been developed and used in mouse and human intestinal epithelial stem cells to improve
the efficiency of primary stem cell expansion (73, 74). This method could also be applied to the
propagation of bladder epithelial stem cells to substantially increase the number of primary
urothelial cells. I hypothesize that primary urothelial culture on a permeable Transwell membrane
will form differentiated multilayers with apical-basal polarity, thereby providing the means to test
in vitro, under strictly defined conditions, the epithelial response against bacterial infection in
primary cells isolated from C3H/HeN mice with different infection histories.
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To overcome the limitations of tumor cell lines on the study of bladder epithelial
pathobiology, primary epithelial cells can be cultured into differentiated multilayers. The
establishment of differentiated multilayers of urothelium requires in vitro differentiation potential
of urothelial stem cells and an advanced method to expand the culture of primary epithelial stem
cells efficiently. However, traditional primary cell culture methods leave the majority of the cells
to undergo differentiation and thus lose their multipotency, making these methods unsuitable for
the specific expansion of stem cells (75, 76). I hypothesize that the spheroid culture method used
in mouse and human intestinal epithelial stem cells can be used to propagate bladder epithelial
stem cells in the same manner, since the method has been universally used in different intestinal
sites including stomach, small intestine, cecum, and colon by using the same medium (73, 74). I
have successfully adapted this culture method for use in in vitro propagation and extended
passages of primary bladder epithelial stem cells.
This in vitro model of differentiated urothelium will provide a method to investigate
urothelial pathobiology in a biologically relevant manner. I hypothesize that primary urothelial
culture on a permeable Transwell membrane will form differentiated urothelium with apical-basal
polarity. With terminally differentiated superficial facet cells (which other immortalized cell lines
lack), I can investigate urothelial interaction with UPEC during early acute infection. It is possible
that primary urothelial culture may not be fully differentiated and may lack terminally
differentiated superficial facet cells to support intracellular bacterial replication and/or IBC
formation. In that case, I can still use this urothelium to study intermediate epithelial cell response
to UPEC infection. During exfoliation, intermediate epithelial cells are exposed to UPEC strains
and interact with them. Differentiated epithelium may be used to study bacterial interactions with
epithelial cells regardless of terminal differentiation of superficial facet cells.
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Our published proteomics and transcriptomics studies of bladder epithelial cells and whole
urinary bladders, respectively, provide substantial evidence that the urothelial differentiation
program is altered in the bladders of Sensitized mice during disease convalescence compared to
adult Naïve and Resolved mice (3, 64). During the convalescent period, the bladders of Sensitized
and Resolved mice that are treated with appropriate antibiotics to clear the initial infection
regenerate differentiated urothelium through the proliferation of urothelial stem cells. However,
even after 6 months of convalescence, sufficient time for the bladder to reestablish polarized
urothelium, experienced mouse bladders still possess altered morphology and pathobiology
against a subsequent infection (70) suggesting the possibility of inheritable genetic changes.
Bacterial pathogens are known to have the ability to trigger epigenetic changes to epithelial cells
during chronic infection (64), and UPEC has been shown to induce methylation of cell cycle genes
by increasing the expression of DNA methyltransferase (77). Thus, I hypothesize that pathogenic
bacteria can be considered as potential epimutagens able to reshape the epigenome and that the
bladder epithelial stem cells in the basal layer play a critical role in modulating bladder mucosal
defense and remodeling upon bacterial infection. Their effects may generate specific, long-lasting
imprints on host cells, leading to infection memory that influences immunity and may contribute
to the origin of other unexplained diseases.
These studies should reveal potential roles of epigenetic changes in urothelial remodeling
as a consequence of prior infection that impact susceptibility to recurrent infection. I anticipate
that the transcriptomic and epigenetic studies of urothelial stem cells will define clear gene
regulation and expression patterns that distinguish Sensitized mouse bladder cells from Naïve and
Resolved mice. A potential difficulty with these studies will be analyzing and organizing large sets
of data from ATAC-seq to understand their biological significance. If the difference between cells
15

from convalescent mice is unclear, I can focus on studying the epigenetic changes of differently
expressed proteins and genes observed in proteomic and transcriptomic analysis of whole bladders,
and then investigate closely related signaling pathways. If the genes of upregulated proteins are
hypersensitive to DNase I and the genes of downregulated proteins are not, it will implicate
epigenetic regulation in epithelial remodeling of Sensitized mouse bladder. I can then deplete or
overexpress genes encoding these differently expressed proteins to investigate their effects on the
epithelium in vitro in order to further understand their role in resistance or susceptibility to
challenge infection.
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1.4 Figures

Fig. 1. Pathogenesis of UPEC infection. The stages of UTI pathogenesis include initial bladder
colonization and the IBC cycle (A-E), the chronic bladder outcomes of quiescent intracellular
reservoir (QIR) formation (F) and chronic cystitis (G), and ureteral ascension and pyelonephritis.
Figure is modified from O’Brien et. al. 2016 (78).
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Fig. 2. A prior bladder infection alters the pathophysiology of rUTI. Time course illustration
of rUTI mouse model. 8 week old female C3H/HeN mice were infected with 108 cfu of UTI89. To
monitor infection outcomes, urine was collected at 1, 3, 7, 10, 14, 21, and 28 days post-infection
(dpi). Persistent high titer (> 104 cfu/ml) bacteriuria is a specific and sensitive cutoff for detecting
chronic cystitis. Chronic cystitis during initial infection was defined as persistent high bacteriuria
(>104 cfu/ml urine) at every time urine was collected, while resolution of cystitis was defined as
urine bacterial titer dropping below the cutoff (104 cfu/ml urine) at least one time point. C3H/HeN
mice develop chronic cystitis in an infection does-dependent manner and this inoculum results in
chronic cystitis in ~50% of mice (Sensitized mice) with the rest spontaneously resolving infection
(Resolved mice). After 4 weeks of initial infection and 4 weeks of convalescent period, mice were
challenge infected with 107 cfu of UTI89 for 4 weeks. Infection outcomes were assessed by
longitudinal urinalysis and measuring cytokines and tissue titer at sacrifice.
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Chapter 2: Differentiated urothelial culture
enables an investigation of host-pathogen
interactions in urinary tract infection

2.1 Abstract
Urinary tract infection (UTI) has previously been studied using genetically and biologically
defined animal models as well as immortalized epithelial cell lines for in vitro studies. There have
been significant efforts to utilize primary bladder epithelial cells to recreate differentiated
urothelium and model bladder biology in vitro. However, the low efficiency of primary cell
expansion has made it difficult to culture stratified urothelial barriers and perform complicated
functional assays, leading many researchers to use immortalized or tumor cell lines for in vitro
studies. Here, I established a novel system to grow primary urothelial stem cells and differentiate
them to form a stratified epithelium with characteristics of the urothelium of the bladder on a
Transwell membrane, allowing us to better study in vitro the interactions between uropathogenic
bacteria and urothelial cells. I measured the expression of terminal differentiation markers as well
as transepithelial electronic resistance (TER) to verify the differentiation state of cultured
urothelium. I found that this primary urothelium better recapitulates bladder biology than tumor
cell culture, in part because it contains differentiated superficial facet cells which are identified by
their large size, hexagonal shape, and binucleate status. I found that primary superficial facet cells
not only appear similar to in vivo cells but also possess biologically relevant binding phenotypes
corresponding with those seen in vivo with uropathogenic E. coli (UPEC), supporting their use for
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the study of host-pathogen interactions. In addition, this system can be readily used to establish
cell lines from different genetic mouse strains as well as mice with different infection histories or
even from patient biopsy specimens. This primary culture system represents a significant advance
in the study of bladder mucosal responses and has significant potential for translation into human
clinical studies.

2.2 Introduction
Uropathogenic Escherichia coli (UPEC) are the major causative agent of uncomplicated urinary
tract infections (UTIs). UPEC strains undergo a unique intracellular infection cycle with the
formation of intracellular bacterial communities (IBCs) within the superficial facet cells of the
bladder epithelium. Once UPEC strains invade into superficial facet cells, they undergo extensive
intracellular proliferation to form large (>104 bacteria) cytosolic, biofilm-like IBCs by 6 to 24 h
postinfection (1, 2). Because their replication occurs within an intracellular niche, IBCs are
protected from many aspects of the host immune responses as well as from antibiotic therapies,
which do not efficiently enter epithelial cells (3). IBC formation also facilitates the efficient spread
of bacteria as it allows replication of large number of bacteria within one IBC cycle that then seed
new rounds of IBC formation by infecting neighboring cells (4, 5), making this step a critical
virulence mechanism for UPEC pathogenesis. However, the details of the mechanism behind IBC
formation is largely unknown, partly because no one has successfully reproduced IBC formation
in vitro using cell line culture without any cell structure disruptions (6, 7).
Human bladder carcinoma cells (ATCC HTB-9 [5637]) have been widely utilized for the
in vitro study of UPEC interactions with bladder cells due to the rapidity and simplicity of this
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model. However, tumor cell culture has significant limitations for the study of urothelial biology
and host immune response to UPEC strains. First, tumor cells often have biological networks and
signaling pathways that are affected by epigenetic dysregulations, making them difficult to utilize
for genetic and functional studies of normal urothelial biology (8, 9). For example, most in vitro
models using urothelial tumor cell lines have failed to reproduce the differentiated cell layers seen
in normal human urothelium (10). To recreate the differentiated urothelial tissue components in
vitro, there have been many efforts to culture primary or immortalized urothelial cells (11, 12).
Previous primary cell culture systems were cumbersome and inefficient in cell expansions, making
them difficult to develop polarized stratified layers of urothelial cells or to utilize for complex
immunologic studies. Recently, the field of primary cell culture has advanced allowing us to adapt
a method for the in vitro propagation of intestinal epithelial stem cells from mice and humans to
easily culture primary bladder epithelial stem cells, facilitating extended passages of primary
urothelial culture (13, 14).
Here I established a culture system of stratified, polarized urothelium using primary
urothelial stem cells (USCs) isolated from mice and passaged in three-dimensional (3D)
“spheroid” culture in basement membrane matrix (Matrigel) prior to seeding on a Transwell
membrane. This urothelial model system allows us to explore the complex nature of host-pathogen
interactions involved in UTI and to compare the urothelial biology of different genetic mouse
strains as well as mice with different infection histories. The formation of intact urothelial barriers
with tight junction formation was confirmed by TER measurements, and the full differentiation of
primary urothelial culture was shown by the surface expression of differentiation markers. I then
characterized the cells by examining the urothelial cell morphologies and functionally tested the
urothelial response against UPEC infection, including bacterial invasion and intracellular
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replication, using different UPEC strains. I observed that differentiated urothelium showed a
different binding phenotype for a UTI89 FimH A27V/V163A mutant strain, which has highaffinity binding to urothelial cells, relative to wild type UTI89. In previous studies, we showed
that UTI89 FimH A27V/V163A strain displays attenuated infection outcomes in vivo while
infection assay with 5637 cells showed no difference in bacterial burdens and biofilm formation
was enhanced (15, 16). Here, I provide molecular evidence to explain these attenuated infection
outcomes despite the higher binding phenotype using differentiated urothelium in vitro. This
primary cell culture and differentiated urothelium model represent a significant advance in the
study of bladder mucosal responses and has great potential for translation to human clinical studies.

2.3 Results
2.3.1 Spheroid culture facilitates extended passages of primary urothelial
stem cells with differentiation potential
There is no single experimental system to model primary bladder epithelial cells that provides a
complete understanding of urothelial biology. A new modelling approach with an advanced cell
culture method in combination with animal models is required to advance our molecular
understanding of bladder epithelial responses to infection. Unlike most of the mucosal epithelial
tissues throughout the body, bladder epithelial tissues are made of stratified transitional epithelial
cells. The differentiation status of urothelial cells is critical for UPEC pathogenesis such as cell
invasion, intracellular replication, and formation of persistent reservoirs, however it has been
challenging for in vitro systems to recapitulate full maturation of urothelium in vivo, likely due to
the lack of an efficient method to culture primary urothelial cells as polarized multilayers (17).
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To establish differentiated urothelia, I needed to develop a method to efficiently culture,
propagate, and differentiate primary USCs in vitro. I have satisfied these requirements by adapting
a 3D culture method for the in vitro propagation of primary intestinal epithelial stem cells (13, 14)
for use in culturing USCs. To validate this approach, I first isolated primary urothelial cells from
a single bladder of 8 week old Naïve C3H/HeN mice and cultured the cells suspended in Matrigel)
with 50% conditioned media (CM) from L cells expressing Wnt, R-spondin and noggin (L-WRN)
to promote proliferation and suppress differentiation (Fig. 1A, S1A). Supplementing the 50% CM
with Y27632, Rho-associated protein kinase (ROCK) inhibitor, and SB431542, the transforming
growth factor (TGF) β type I receptor inhibitor can maximize early growth of developing primary
spheroids from mouse bladders by preventing cell apoptosis and differentiation (13, 14). Matrigel
is a gelatinous protein mixture enriched for basement membrane proteins and it has been used
successfully for the growth of mammary epithelium culture because it retains the stem cells in an
undifferentiated state (18). USCs can be passaged every 3 days of culture and remained healthy
and retained their phenotype for > 30 passages for > 90 days. The media was changed every 2
days.
In order to evaluate the pluripotency and Wnt signaling activation state of the USCs in this
culture system, I measured the expression of Trp63, which encodes the stem cell marker
transformation-related protein 63 (p63), and Axin2, a Wnt-target gene (14), by RT-qPCR (Fig.
S1B-D). Trp63 and Axin2 gene expression remained high through the first 3 days of culture in
50% CM, then decreased by 5 to 7 days. Switching to 5% CM after 3 days also reduced expression
of Axin2 at 5 days, showing that extended culture or lower CM percentage can reduce Wnt
signaling. Expression of uroplakin-3a (Upk3a), a surface protein expressed by differentiated
urothelial cells, was significantly increased in 5% CM compared with 50% CM at 7 days (Fig.
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S1D), indicating that the USCs had begun to differentiate. After propagation of USCs in 50% CM
over several passages, culturing in 0% CM in 3D culture for 5 days resulted in the development of
epithelial polarity with the formation of a central cavity (Fig. S1E). Within the resulting cysts,
cavity-facing cells differentiated into superficial facet-like cells with the expression of Upk3a. In
contrast, perimeter cells in contact with the matrigel matrix were positive for the basal urothelial
cell marker cytokeratin (CK) 5.

2.3.2 Transwell culture of primary urothelial cells forms differentiated
polarized urothelium
I next established a Transwell culture system to differentiate USCs of juvenile C3H/HeN
mice into polarized, stratified urothelial barriers. Human bladder carcinoma cells, 5637, were also
cultured in Transwells to compare differences between primary USCs and cancer cell lines.
Primary USCs were seeded and cultured on the Transwell for 2-3 weeks (Fig. 1A). Urothelial
spheroids harvested from two to three wells of a 24-well plate after 3 day culture were enough to
seed a single 0.33 cm2 Transwell insert of a 24-well plate (seeding density of 3-4 x 105 cells/well).
Urothelial cells were then cultured in 50% CM supplemented with 10 mM of Y-27632 to maximize
early growth of primary cells for 5 days and the media was changed every 2 days during this initial
culture. After the primary epithelial cells were expanded sufficiently, the media was replaced with
5% CM and changed with fresh media every 2 days allowing urothelial cells to differentiate into
a polarized urothelium for 2-3 weeks.

The formation of intact urothelium was confirmed by measuring robust TER (Fig. 1B).
Since the TER measurement represents the assembly state of the tight junctions by the cells, I
expected that the urothelium would have increased TER coordinately with cell growth and
culminate with a stratified and differentiated urothelial barrier, where the tight junction proteins
31

assemble and strengthen, and reach the maximum TER when fully differentiated. I cultured the
urothelial cells in 50% CM until their TER increased to 600-700 ohm*cm2. The media was then
switched to 5% CM for the differentiation and the cells rapidly increased TER to 4000-4500
ohm*cm2. As expected, differentiated urothelium on the Transwell had much higher TER than
other epithelial cell lines due the stratified nature of the urothelial barrier (19, 20). Robust TER
indicated the cultured urothelium formed intact barriers and could be used for various in vitro
functional studies such as bacterial infection assay. In contrast, 5637 cells did not increase TER
during 2 weeks of culture in the same differentiation conditions (Fig. S2A).

The examination of the differentiated urothelia by confocal microscopy demonstrated that
the apical surface was lined by large hexagonal superficial facet cells that were positive for the
terminal differentiation marker CK20 (Fig. 1C), while 5637 cell cultures showed small round cells.
(Fig. S2B-C). The surface of differentiated urothelia was characterized by the presence of cell
junctions and uroplakin plaques (Fig. 1D), similar to how superficial facet cells appear on the
surface of intact bladder tissues (21), along with the surface localization of terminal differentiation
markers UPK3 and CK20. The stem cell marker TRP63 was expressed in the basal cells, with the
epithelial cell junction marker E-cadherin (ECAD) expressed on the basolateral surface of all cells
observed, confirming that there was no contamination of other cell types such as immune cells
(Fig. 1E). In contrast, although 5637 cells could form layers of four to six cells on Transwells, the
cells were loosely connected to each other and lacked evidence of polarization or junction
formation when stained with differentiation markers (Fig. S2D). Altogether, the distribution of
these differentiation characteristics in basal and superficial urothelial layers is consistent with what
is observed in mouse and human bladder tissue and indicated that differentiated primary
urothelium on the Transwell provides significant advantages over a tumor cell line for studying
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the biology of urothelium. As mentioned previously, proper differentiation of UPK3, directly
correlated with the terminal maturation of urothelial cells, is critical for E. coli mediated cell death
(17, 22). Thus, this system demonstrates important characteristics for complex studies of urothelial
interaction with UPEC strains.
Epithelial differentiation can be promoted by culturing primary urothelial stem cells in
serum free media. I have tested four different conditions to find the optimal condition to
differentiate in vitro urothelium; 0% CM in primary culture media including 20% FBS, 5% CM in
primary culture media including 20% FBS, 0% CM in serum free base media and 5% CM in serum
free base media. After culturing in these conditions, I confocal stained the differentiated urothelia
for CK20, UPK3A, and F-actin (Fig. S3A-D). Differentiated urothelia in all conditions showed
expression of CK20 and UPK3A with proper localization on the surface without significant
differences between the conditions. However, surface cell size measurement of differentiated
urothelia in these four different conditions showed that urothelial cells differentiated with 5% CM
in serum free media were significantly bigger compared to 0% CM in primary media (Fig. S3E).
Therefore, 5% CM in serum free media was chosen for all further urothelial differentiation studies

2.3.3 Host-pathogen interactions using primary urothelial culture
We then tested the ability of type 1 pilus mutants to adhere to the differentiated primary
urothelium. Once UPEC enters the bladder, bacterial colonization and subsequent invasion into
the superficial facet cells is facilitated by the type 1 pilus adhesin FimH (23). Type 1 pili are hairlike fibers tipped with the FimH adhesin that binds mannose with stereochemical specificity.
FimH is joined to the tip via FimG. FimF adapts the tip complex to the FimA rod. FimH is critical
to facilitate bacterial colonization and invasion of bladder epithelial cells and the formation of
IBCs. The plasticity of the type 1 pilus rod, comprised of repeating units of FimA arranged in a
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right handed helical fiber, is also critical for these functions (24). Bladder invasion is a critical
pathogenesis step allowing bacteria to replicate in a niche protected from the innate immune
system, antibiotics and expulsion during urination. Thus, UPEC lacking the ability to invade the
urothelium, including those lacking type 1 pili are quickly cleared from the bladder. An intensive
structure-function analysis has elucidated many of the key interactions made by all of the subunits
in the type 1 pilus. Mutations disrupting critical interactions have been extensively studied in: i)
mouse models of UTI; ii) in vitro cell culture systems using 5637 tumor cell line; and iii)
hemagglutination (HA) assays using guinea pig red blood cells (15, 24). The critical host-pathogen
interactions occur between FimH and the luminal terminally differentiated superficial facet cells
of the bladder. Therefore, interactions made with bladder tumor cell lines or conventional
immortalized cell lines do not reflect the key host-pathogen interactions in the bladder, since these
are derived from transitional cells (14). Thus, I hypothesized that UPEC interactions with my
differentiated urothelium model would better reflect in vivo pathogenesis. To assess this, I used a
FimH mutant strain that has been shown to have an attenuated infection phenotype in the mouse
UTI model and requires further in vitro functional studies. FimH is a two-domain protein: the
lectin binding domain linked to the pilin domain in the shape of a boomerang (15). Three residues
under positive selection control a conformational equilibrium of the two domains with respect to
one another. Depending on the identity of these residues, the equilibrium can shift to either a tense
conformation, which binds mannose with low affinity, or the relaxed conformation that binds
mannose with high affinity. Thus, the UTI89 FimH A27V/V163A variant has been known to
exhibit high affinity binding to the mannosylated uroplakin receptor on the urothelial surface.
Interestingly, this strain is attenuated in the mouse UTI model, even though it binds mannose with
high affinity.
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For the in vitro Transwell infection assay, UTI89 wild type (25) was used as a positive
control. I infected the differentiated urothelia on the Transwell with UTI89 WT and UTI89 FimH
A27V/V163A strains for 4 hours and further investigated their adherence and invasion into the
urothelial cells using scanning electron microscopy (SEM) and immunofluorescence.
Interestingly, SEM imaging of the infected differentiated urothelia showed that UTI89 FimH
A27V/V163A strains adhered dramatically better to the surface of urothelium compared to UTI89
wild type (Fig. 2A-B). Confocal microscopy was used to assess any differences in the number of
intracellular bacteria between the strains by staining with F-actin and nuclear DNA. When UPEC
strains adhere and invade the urothelial cells, the bacteria will be covered by F-actin showing the
colocalization of E. coli (green) and F-actin staining (red). 3D z-stock confocal images showed
that UTI89 FimH A27V/V163A strains are almost exclusively extracellular (green) while
intracellular bacteria (yellow) were observed for the UTI89 WT strain (Fig. 2D-E). Thus, the lack
of invasion of the UTI89 FimH A27V/V163A strain may explain why it is attenuated, despite its
ability to bind to superficial facet cells significantly better than wild type.

2.4 Discussion
The stratified nature of the polarized bladder epithelium makes it difficult to recreate the
urothelium in vitro using tumor cell lines or primary cell lines due to the lack of differentiation
potential or highly inefficient cell expansion respectively. As a result, most of the UTI studies have
relied on murine models of UTI, or tumor cell lines for in vitro studies despite their undifferentiated
natures. In this study, I established a culture system of polarized urothelium using primary
urothelial cells isolated from mouse bladders with great potential for use in various in vitro studies
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of urothelial interactions with UPEC strains. The key advantages of this culture system include
use of individual mouse bladders for generating primary epithelial cell lines and reproduction of
the polarized urothelium that can be used for in vitro UPEC infection assays. By generating a cell
line from an individual mouse, I can perform multiple experiments with the same cell line over
time. Spheroid culture of the urothelial stem cells enables functional assays to characterize each
urothelial cell line such as RT-qPCR, whereas differentiated urothelium allows studies of
urothelial interaction with UPEC strains. Many of the unique characteristics of UPEC pathogenesis
depend on host-pathogen interactions with the terminal differentiation of urothelial cells (17), thus
the differentiated urothelium can be readily used to understand the complex nature of UPEC
pathogenesis including adherence and invasion. In addition, Transwell culture systems have
separate upper and lower chambers allowing assessment of both apical and basal lateral processes.
Further, co-culture experiments are possible. Immune cells can be added to the apical or basolateral
side of the urothelium to further study the interaction between urothelial cells and UPEC in the
presence of immune compartment components.
Another advantage of this culture system is that I can generate cell lines originating from
any source of bladder tissue including genetically modified mouse strains, mice that have different
UTI histories, as well as patient biopsy specimens. This will provide an in vitro system to
investigate how host genetic backgrounds and infection histories affect host susceptibility to UTI
and rUTI, along with the possible translation into patient-specific studies. Previous studies using
a murine model of rUTI have shown that a prior history of infection causes bladder remodeling,
which makes the experienced mice more susceptible to the secondary challenge infection (21, 26).
Application of this culture system to isolate primary cell lines from mice with an infection history
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or patient biopsies will provide a platform to study the contribution of bladder epithelial cell
intrinsic factors on the bladder remodeling and predisposition to the secondary infection.
This advanced culture system of differentiated urothelium is more appropriate for studying
the urothelial adherence of UPEC than tumor cell lines. Using differentiated urothelium, I found
molecular evidence elucidating thet attenuated infection phenotype of UTI89 FimH A27V/V163A
strain. As adherence and invasion into the urothelial cells are critical for the pathogenesis of UPEC
strains, UPEC lacking these abilities have attenuated infection outcomes in a murine UTI model
compared with wild type. Interestingly, UTI89 FimH A27V/V163A has an attenuated infection
phenotype in mice even though FimH A27V/V163A binds to mannose receptor with higher
affinity than wild type FimH adhesin (15). Previous UPEC infection assays with 5637 tumor cell
culture showed the FimH mutant strain invaded the urothelial cells at a similar or higher level than
UTI89 wild type (15). This led to the hypothesis that the attenuated phenotype of FimH
A27V/V163A could be due its binding to decoy molecules resulting in its elimination from the
bladder. However, using the differentiated primary urothelium, I have discovered that FimH
A27V/V163A is defective in invasion, which may better explain the attenuation phenotype
observed in vivo despite it being a better binder than wild type UTI89. This supports the hypothesis
that UPEC is required to have moderate affinity in binding to urothelial cells for virulence and
suggests that high-affinity binding to the superficial urothelial cells hinders the invasion of bacteria
into the cells. This shows the importance of having an advanced in vitro system to properly
investigate the pathobiology of UTI. As differentiated urothelium provides more biologically
relevant urothelial surface, we can glean new insights about urothelial interaction with various
UPEC strains through this in vitro infection study.
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2.5 Figures

Fig. 1. The culture of urothelial stem cells (USCs) of juvenile C3H/HeN mice regenerates
differentiated urothelium in vitro. (A) USCs isolated from 8 week old C3H/HeN mice are
expanded by spheroidal culture in matrigel with 50% L-WRN conditioned media (CM) including
Y27632, ROCK inhibitor, and SB431542, TGF β type 1 inhibitor. After 3 days of spheroid culture,
cells are dissociated into a single cell suspension and 3-4x105 cells were seeded onto the Transwell
membrane. The cells are cultured in 50% CM for 3-5 days then cultured in 5% CM for 2-3 weeks
until full differentiation. (B) Cell cultures with a TER value >4000 ohm*cm2 were then analyzed
(5 Transwells cultured from one juvenile C3H/HeN cell line). For consistency, TER was measured
1 day after media change. (C-D) Differentiated urothelia on the Transwells were fixed and imaged
via (C) confocal microscopy and (D) scanning electron microscopy (SEM) to show the top-down
view of urothelium. In (C) samples were stained for F-actin, the terminal differentiation marker
CK20, and nuclei (DAPI). (E) The urothelia were also paraffin-embedded, sectioned and
immunostained for: epithelial differentiation markers UPK3A and CK20, epithelial junction
marker E-cadherin, stem cell marker TRP63, and nuclear marker DAPI. Representative images are
shown. Data come from 2-3 independent experiments using USCs from 5 different juvenile
C3H/HeN mice.
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Fig. 2. Adherence assay using differentiated urothelia recapitulates urothelial interaction
with various pili mutant UPEC strains. Differentiated urothelia were infected with (A) UTI89
wild type and (B) UTI89 FimH A27V/V163A at MOI 50 for 4 hours, then processed for SEM. (C)
UTI89 wild type and (D) UTI89 FimH A27V/V163A infected differentiated urothelia were
immunostained for F-actin (red), E. coli (green), and nuclei (blue) then imaged as z-stack confocal.
The colocalization of E. coli (green) and F-actin (red) staining indicates intracellular bacteria or
invading bacteria.
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Fig. S1. Primary epithelial stem cells possess differentiation potential and stemness, related
to Fig. 1. (A) For the cell expansion, dissociated cell aggregates were embedded in fresh matrigel
then developed into new spheroids. Urothelial spheroids can be passaged every 3 days using 1:2 –
1:3 dilutions depending on cell density. (B-D) Primary USCs originated from 8 weeks old
C3H/HeN mice were cultured in matrigel with 50% CM. After 3 days of culture in 50% CM, media
were changed to fresh 50% CM or 5% CM at 3, 5, and 7 days, then RNAs were isolated at 1, 2, 3
(yellow), 5 (green), and 7 days (orange). (B) Gene expressions of Trp63, stem cell marker, (C)
Axin2, Wnt signaling marker, and (D) Upk3a, urothelial cell differentiation marker, were measured
by RT-qPCR and data are represented as mean ± SD. (E) To culture bladder organoids in matrigel,
USCs were pre-cultured in 50% CM for 3 days, gently dissociated, then passaged into fresh
matrigel for culture in 50% CM or 0% CM for 5 days, while media were changed every 2 days.
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After 5 day culture, USC spheroids were fixed with 10% neutral buffered formaldehyde (NBF)
and prepared for paraffin embedding. The slide with paraffin sections were stained with
hematoxylin and eosin (H&E) and immunostained for UPK3A (red), E-cadherin (yellow), and
DAPI (blue) or CK20 (red), CK5 (yellow), and DAPI (blue).
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Fig. S2. The differentiated urothelium better recapitulates the bladder tissue in vivo
compared with human bladder carcinoma cell line, 5637, related to Fig. 1. (A) Primary
C3H/HeN urothelial cells and 5637 cells were cultured in Transwells for 2-3 weeks and
transepithelial electrical resistance (TER) of Transwells were measured every 2 days before media
change. (B) Whole mount urothelium of both cells were also fixed and stained for confocal
staining; F-actin (green) and nuclei (blue). (C) Surface cell size of each primary C3H/HeN
urothelial cell and 5637 cell culture was measured using confocal images. Data are represented as
mean ± SD. (D) The Transwell cultures of both C3H/HeN and 5637 cells were fixed, cut into slices
and then processed for paraffin embedding. Histologic sections were cut and stained with H&E or
immunostained for UPK3A (red), CK20 (red), E-cadherin (yellow), CK5 (yellow), Trp63
(yellow), and DAPI (blue).
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Fig. S3. Both 0% and 5% CM induce differentiation of urothelial cells on Transwell
independent to the presence of serum. Primary C3H/HeN urothelial cells were cultured on
Transwell for 2 weeks. After initial 5 days of initial culture in 50% CM, each sample was further
cultured in (A) 0% CM in primary culture media including 20% FBS, (B) 5% CM in primary
culture media including 20% FB, (C) 0% CM in serum free base media, and (D) 5% CM in serum
free base media. Whole mount urothelia were fixed and stained for confocal staining; CK20
(white), UPK3A (violet), and F-actin (green). (E) Surface cell size of differentiated urothelia in
four different media condition were measured using confocal images.
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2.6 Materials and Methods
Ethics statement
All animal experimentation was conducted according to the National Institutes of Health
guidelines for the housing and care of laboratory animals. All experiments were performed in
accordance with institutional regulations after review and approval by the Animal Studies
Committee at Washington University School of Medicine in St Louis, Missouri.
Bacterial strains
The UPEC strain primarily used in this study was a kanamycin-resistant derivative of the human
cystitis isolate UTI89 (25): UTI89 attHK022::COM-GFP (UTI89-KanR) (27). For enumeration of
intracellular bacteria by epifluorescence microscopy, I used UTI89 pANT4, which contains a
plasmid that constitutively expresses eGFP. For both mouse and in vitro infection, UPEC strains
were cultured statically in lysogeny broth (LB) at 37 °C. UTI89 inocula were prepared as
previously described by spinning down the cultures at RT for 10 min at 3000 g, resuspended in 10
ml PBS, and diluted to approximately 2-3x109 cfu/ml (OD600 = 3.5) (26).
Host cell culture
Human BECs, designated 5637 (ATCC HTB-9) cells, were obtained from the American Type
Culture Collection and maintained in RPMI 1640 supplemented with heat-inactivated 10%
(vol/vol) FBS at 37 °C in the presence of 5% CO2.
Primary USC isolation
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The primary USC isolation and culture system was adapted and modified from primary intestinal
epithelial cell culture method described in (13). Bladder tissue from 8 weeks old juvenile Naïve
C3H/HeN mice and convalescent mice (Naïve, Resolved, and Sensitized after initial infection and
antibiotic treatment) were isolated and bisected, incubated in 1 ml of stripping solution at 4 °C for
overnight. The urothelial cells were scrapped off from the bladder tissue using two forceps on
sterilized tissue culture plate. Collected urothelial cells were then spun down at 4 °C at 300 g for
5 min, resuspended in 1 ml of fresh collagenase IV solution, and incubated with rocking at 37 °C
for 20 min. The cells were disaggregated by gentle pipetting, filtrated with 100 µm strainer, washed
with 1 ml of washing media, then cultured in matrigel with 50% CM as described in 3D spheroid
cell culture. Initial culture might contain some non-stem urothelial cells, so the cells were used for
experiments after 10 passages.
3D spheroid cell culture
Primary bladder epithelial cells were isolated, grown, and maintained as 3D spheroid cultures in
Matrigel (BD Biosciences, San Jose, CA) as described in (13). Cells were kept in 50% L-WRN
CM containing 10 mM Y-27632 and 10 mM SB431542 (R&D System, Minneapolis, MN). Media
were changed every 2 days, and cells were passaged every 3 days (1:2-3 split). Spheroids at various
passage numbers were cryopreserved for future use, then thawed when needed as previously
described (13).
Urothelium culture on Transwell
Spheroidal USCs at 3-day 3D culture were recovered from Matrigel by washing in PBS with 0.5
mM EDTA, and then trypsinized in 0.05% Trypsin, 0.5 mM EDTA for 1 min at 37 °C. The trypsin
was then inactivated by adding washing media then spheroids were dissociated by vigorous
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pipetting (using a double tip technique). The cells were then filtered through a 40 µm cell strainer
(BD Biosciences) and resuspended in 1 ml of washing media. The Transwells (3413; Corning
Costar, Tewksbury, MA) were coated in PBS with 1:40 Matrigel for 30 min at 37 °C. Then the
cell numbers were counted using hemocytometer under microscope. 3-4x104 cells in 100 μl of
50% L-WRN CM containing 10 mM Y-27632 (ROCK inhibitor) were seeded on top of the
Transwell insert. An additional 600 μl of 50% CM were added to the apical compartment of the
Transwells. On average, single cell suspensions from three wells of a 24-well spheroid plate were
enough to seed a single Transwell.
Transepithelial electrical resistance (TER) measurements
TER was measured for cells in Transwells using an epithelial volt-ohm meter (World Precision
Instruments, Sarasota, FL). Resistance of the urothelial multilayers was calculated by subtracting
the resistance of the (membrane + media) from the resistance of the (membrane + media + cells).
Each Transwell was measured in triplicate and the average value was taken. This value was then
multiplied by the area of the Transwell membrane (0.33 cm2) to obtain a final value in ohm*cm2
(28).
In vitro UPEC infection assay
When the Transwell is fully differentiated (TER value > 4000 ohm*cm2), the Transwell inserts
were washed in warm DMEM/F12 media for three times and infected with UPEC strains at
intended MOI (1, 5, 10, 50, and 100) or other stimuli. The infected Transwells were incubated at
37 °C for 30 min, changed media containing 100 µg/ml gentamicin to clear the extracellular
bacteria, and cultured for extended time. After infection, luminal and apical media were spun down
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at 2000 g at 4 °C for 5 min, froze at -20 °C for analysis if indicated. The Transwells were washed
with sterile PBS then used for various analysis.
Whole-mount confocal staining
The cells cultured on Transwells or chamber slides were washed and fixed in PBS with 4%
paraformaldehyde (PFA) for 15 min and rinsed three time with PBS. 100 µl of 0.2% Triton-X was
treated for 10 min then dumped, and the cells were incubated in 100 µl of 2% BSA in for blocking
for 30 min. After primary and secondary antibody staining and associated washes, the samples
were stained with Alexa Fluor 555 Phalloidin (Molecular Probes binding to F-actin) and 4′,6diamidino-2-phenylindole (DAPI). The samples were mounted in ProLong Gold Antifade
Mountant (Thermo Fisher), then examined by confocal microscopy on a ZEISS LSM880 Laser
Scanning Microscope with Airyscan. Fiji ImageJ and macro program were used to automatically
calculate epithelial cell surface area in z-stacked confocal images.
Histopathology and immunofluorescence
USC spheroids or urothelium on the Transwells were fixed overnight in 10% formaldehyde at RT
or 4 °C. After wash in PBS, the fixed samples are pre-embedded into 2% agar, cut vertically, put
the Transwell side face up, embedded again in paraffin blocks, and sectioned. The slides were
stained for H&E and immunostained for selected antibodies. For immunofluorescence staining,
slides were deparaffinized, hydrated, blocked with 10% heat-inactivated horse serum (HIHS) and
0.3% triton X-100 in PBS, incubated with primary antibody in 1% HIHS and PBS overnight at 4
°C and secondary antibody in PBS for 30-60 min at RT (21). The primary antibodies used were
uroplakin-3 (mouse monoclonal, 10R-U103a, Fitzgerald), Trp63 (rabbit polyclonal, GTX102425,
GeneTex), E-cadherin (goat polyclonal IgG, AF748, R&D Systems), cytokeratin 5 (chicken
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polyclonal, 905901, BioLegend) and cytokeratin 20 (mouse monoclonal, M7019, DAKO). Nuclei
were stained with Hoechst (Thermo fisher). Samples were mounted in ProLong Gold Antifade,
and fluorescence was visualized on a Zeiss Axio Imager M2 Plus wide Field Fluorescence
microscope. Antibodies are verified at 1DegreeBio (http://1degreebio.org/), except cytokeratin 5
and cytokeratin 20 (verified at manufacturers’ websites) (21).
Scanning electron microscopy
Urothelium on the Transwell inserts were washed 3 times in PBS, fixed in EM fixative (2%
paraformaldehyde, 2.5% glutaraldehyde in 1x PBS) for 1 hour on ice, and washed 3 times in PBS.
Samples were then post-fixed in 1.0% osmium tetroxide, dehydrated in increasing concentrations
of ethanol, then dehydrated at 31.1 °C and 1,072 p.s.i. for 16 min in a critical point dryer (21).
Samples were mounted on carbon tape-coated stubs and sputter-coated with gold/palladium under
argon (21), then they were imaged on a Zeiss Crossbeam 540 FIB-SEM.
RNA isolation and RT-qPCR
Spheroids or cells on the Transwell were treated with reagents or infected with UPEC before RNA
isolation. RNA was extracted using the RNAeasy Plus Mini Kit (Qiagen) and reverse-transcribed
with iScript Reverse Transcription Supermix (BioRad). RT-qPCR for expression of Ptgs2, Casp1,
Casp4, were performed as previously described (29, 30). 1 μl of 12.5 ng/μl cDNA was used with
intron-spanning primers specific to each gene and iQ SYBR Green Supermix was used according
to the manufacturer’s instructions (Bio-Rad). Expression values were normalized to 18S
expression levels, and the expression fold change relative to mock-infected cells or Naïve cells
was determined by the cycle threshold (ΔΔCt) method (31). Each sample was run in triplicate, and
average Ct values were calculated.
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Quantification and statistical analysis
Statistics were performed in GraphPad Prism v8.3.0. For the cell size differences in confocal
images and RT-qPCR, pairwise comparisons were performed with the Mann–Whitney U test (twotailed) or unpaired Student’s t test. A value of P < 0.05 was considered to be statistically significant.
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Chapter 3: History of urinary tract infection
drives trained immunity through epigenetic
remodeling of bladder epithelial stem cells
3.1 Abstract
A prior history of urinary tract infection (UTI) is associated with long-lasting bladder mucosal
remodeling and altered susceptibility to rUTI in both humans and mice. In a murine model of
recurrent bladder infection: C3H/HeN mice with a history of chronic cystitis that was cleared with
antibiotic therapy become “Sensitized” to severe recurrent UTI (rUTI) upon subsequent UPEC
challenge, while C3H/HeN mice that spontaneously resolved the first infection (“Resolved” mice)
are resistant to challenge infection relative to age-matched “Adult Naive” mice. In addition to
differences in susceptibility to secondary UPEC infection, their bladder tissues showed longlasting differences in superficial facet cell size, differentiation state, and transcriptomics,
indicating bladder remodeling. Here, I have elucidated a urothelial-intrinsic mechanism of mucosal
remodeling by culturing primary urothelial cells isolated from Naïve, Resolved, and Sensitized
mice. I propagated these urothelial stem cell (USC) lines and then cultured and differentiated them
in Transwells. The differentiated urothelial tissue from the various USC lines recapitulated their
respective urothelial remodeling morphology phenotypes observed in vivo, implicating epigenetic
reprogramming of the USCs.
Using ATAC-seq (Assay for Transposase-Accessible Chromatin by sequencing), I found
that chromatin accessibility in the USC lines differed based on the prior disease outcome history
of the mice from which they were harvested, i.e. whether chronic or self-resolving. Notably, the
53

Casp1 promoter region was accessible in USCs from mice with a history of chronic infection that
are “Sensitized” to rUTI, leading to increased Caspase 1 expression and infection-induced cell
death. Upon UPEC challenge of Sensitized mice, I found that both the bacterial burdens during
early acute rUTI and the incidence of recurrent chronic infections were elevated when challenged
with an hlyA null mutant UPEC strain, which does not activate the Caspase 1/4 inflammasome,
relative to the parental strain. These studies have elucidated a critical role for epigenetic
reprogramming of USCs in mediating bladder mucosal remodeling and implicate Caspase1mediated urothelial cell death as a key protective mechanism of trained immunity in the urinary
bladder. The elucidation of trained immunity upon infection has elucidated an important aspect of
the mechanism behind the decades old clinical observation that UTI history is a risk factor for
rUTI. Targeting these mechanisms may lead to novel therapeutic strategies to prevent and/or treat
rUTIs by specifically affecting host processes within the uroepithelium.

3.2 Introduction
Urinary tract infections (UTIs) are one of the most common bacterial infections worldwide and
are a significant cause of morbidity in otherwise healthy females (1, 2). The high recurrence rate
in susceptible individuals makes treatment challenging (3). One of the strongest risk factors for
recurrent UTI (rUTI) is a history of prior UTIs (2), such that over the same time period a woman
who has had a recent UTI is much more likely to have another UTI than a woman who has not had
a previous UTI. While this is clinically well established, the biological basis for this phenomenon
is poorly understood.
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In the absence of effective antibiotic therapy, acute UTIs in humans either self-resolve or
develop into long-lasting chronic infections (4). Infection of C3H/HeN mice with uropathogenic
Escherichia coli (UPEC) recapitulates these two outcomes, i.e. self-resolving within a week post
infection or developing into chronic infection defined as persistent high titer bacteriuria (bacteria
in urine) (>4 weeks) accompanied by chronic bladder inflammation (5, 6).. Analysis of bladders
with these two disease histories, after antibiotic therapy and a 4 week convalescent period, reveals
that infection leads to differential bladder remodeling depending on disease history. Infection of
mice having a history of self-resolution of the initial UTI (herein termed Resolved mice) results in
an accelerated bladder TNFα/cyclooxygenase-2 (Cox-2) response that quickly wanes. This
dynamic response promotes the rapid elimination of infection and hence Resolved mice are
resistant to rUTIs (7, 8). In contrast, mice with a history of chronic cystitis (herein termed
Sensitized mice) (7, 8) are highly susceptible to rUTIs upon challenge, in part due to a robust and
sustained expression of Cox-2 in the bladder that does not wane, resulting in unchecked neutrophil
transmigration across the bladder epithelium (urothelium) and mucosal wounding that promotes
severe recurrent bacterial infections (6, 9). Thus, depending on disease history, the bladder tissue
is differentially reprogrammed in a way that either increases or decreases susceptibility to rUTI.
This led to our hypothesis that bladder remodeling is mediated by epigenetic changes in
urothelial stem cells (USCs) and that the superficial facet cells (the terminally differentiated
bladder cells that are the first to encounter UPEC upon infection) differentiated from these USCs
could exhibit differences in trained immunity based on prior infection history (6, 10). I found that
USCs can be isolated from mouse bladders and propagated in cell culture for many generations
(40 or more passages). I found that USC cultures in Transwell formed polarized and fully
differentiated in vitro urothelium, which will be referred to herein as differentiated urothelium (or
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urothelia). Importantly, I found that differentiated urothelia originating from Sensitized or
Resolved mice displayed morphological phenotypes relative to Naïve (never-infected) mice that
resemble the urothelial remodeling phenotypes observed in vivo (10). I used Assay for
Transposase-Accessible Chromatin using sequencing (ATAC-seq) to identify dramatic differences
in chromatin accessibility in the USCs as a consequence of disease history, which in many cases
corresponded with differences in transcriptional responses, particularly in programmed cell death
pathways (11). These studies are the first to demonstrate trained immunity of bladder epithelial
cells due to bacterial infection-mediated epigenetic changes in the bladder stem cells.
Consequently, the host response to subsequent infections is modified depending on the original
disease outcome. This finding may explain the prevalence of rUTI and may have important
therapeutic implications.

3.3 Results
3.3.1 Differentiated urothelia originating from previously infected mice
maintain bladder remodeling phenotypes
Using our murine model of rUTI (5, 6), we have shown that an initial UTI event results in bladder
remodeling, including structural and proteomic changes to the urothelium, the nature of which
depends on the outcome of the initial infection, i.e., whether chronic or self-resolving. Based on
the long-term characteristics of bladder remodeling, which lasts more than six months in mice
(10), I hypothesized that changes in the bladder USCs play a key role in bladder remodeling. To
investigate the urothelial-intrinsic contribution to bladder remodeling, I have established the 2D
primary epithelial cell culture system and 3D Transwell culture system (Fig. 1). Using these
improved culture systems, I isolated bladder USCs from convalescent mice (four weeks after the
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initiation of antibiotics), both those that self-resolved infection (Resolved), and those that had
developed chronic infection (Sensitized) (Fig. 2A-B). I also isolated USCs from age-matched
Naïve mice as controls (Naïve) and established different USC lines from four mice for each of the
different infection histories. Following the procedures outlined above (Chapter 2) for juvenile
C3H/HeN USCs, I propagated these cell lines 15-30 passages and then differentiated them on
Transwells and characterized each cell line by microscopy after 2-3 weeks of culture.
I found that the urothelium derived from Sensitized USCs recapitulates many of the
morphological differences observed previously in vivo (6) even after several passages, including
smaller surface cells and decreased expression of the terminal differentiation markers UPK3 and
CK20 when compared with differentiated urothelium derived from Naïve USCs (Fig. 2C-E).
Automated measurement of surface cell sizes showed that the apical cells of the Sensitized
differentiated urothelia are significantly smaller than those of the Naïve differentiated urothelia,
whereas apical cells of the Resolved urothelia have an intermediate phenotype, consistent with in
vivo data (Fig. 2F-G) (6). I also observed that differentiated urothelium derived from Sensitized
mice had characteristic differences in cytokine response. Serum biomarkers that predict chronic
cystitis and predisposition to rUTI in human and mice, such as IL-6, granulocyte colonystimulating factor (G-CSF), and CXCL1 (KC), showed increased expression patterns in sensitized
urothelium (Fig. S1A-C). Interestingly, baseline chemokine RANTES expression is suppressed in
urothelia from sensitized mice (Fig. S1D), suggesting a possibility that RANTES could be used as
a marker of Sensitization of USCs. Collectively, these data indicate that morphological differences
in the urothelium associated with bladder epithelial remodeling in previously infected mice can be
recapitulated in differentiated urothelia derived from the USCs isolated from mice with
corresponding infection histories.
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3.3.2 USCs from previously infected mice have differential chromatin
accessibility near inflammatory response genes
Our data showed that a prior infection results in USC-intrinsic changes and that these changes are
heritable over many generations of cell culture. Therefore, I hypothesized that epigenetic changes
occur in USCs as a consequence of an initial UPEC infection. To investigate the presence of
differential epigenetic modification in these USCs, I assayed for genome-wide differences in
chromatin accessibility via Omni-ATAC-seq, a technique for mapping regions of nuclear
chromatin that are accessible to transposases by sequencing (11, 12). I identified a total of 59,801,
63,195, and 82,030 highly reproducible accessible chromatin regions in each Naïve, Resolved, and
Sensitized USCs respectively. Then I identified regions that were differentially accessible regions
(DARs) in USCs from mice with different disease histories by using DiffBind. Principal
component analysis (PCA) using two biological replicates of each type of USC showed that
Sensitized USCs clustered separately from other groups (Fig. 3A). Using differential analysis, I
found that Sensitized and Resolved USCs have distinct chromatin accessibility features with 2880
DARs across the genome (FDR <0.05) (Fig. 3B, Data S1). Among those 2880 regions, 925 regions
are Sensitized-accessible DARs (more accessible chromatin regions in Sensitized than Resolved)
and 1955 regions are Resolved-accessible DARs (more accessible chromatin regions in Resolved
than Sensitized) (Fig. 3C-D).

To investigate whether the genes near these DARs were enriched for any functional
annotation, I performed Gene Ontology (GO) pathway analysis on these DARs using GREAT
(13). This analysis revealed that genes associated with Sensitized-accessible DARs are strongly
enriched for many biological processes involving cell death, oxidative stress, and immune
response. In contrast, genes in Resolved-accessible DARs are enriched for proliferation and
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differentiation related pathways (Fig. 3E-F). These enriched pathways were also previously found
to be enriched in the differentially expressed genes in whole bladder RNA-seq (6), suggesting that
chromatin remodeling in bladder USCs is a key determinant of bladder tissue remodeling due to
chronic cystitis. I also performed RNA-seq of Naïve, Resolved, and Sensitized USCs to assess if
differences in gene transcript levels correlated with differences in their epigenomes. Similar to the
ATAC-seq analysis, PCA of the RNA-seq data indicated that the transcriptional profiles of
Sensitized USCs are different from those of Resolved or Naïve USCs, the latter being similar to
each other based on the proximity of their clusters (Fig. 3G). Sensitized USCs had 108 and 73
differentially expressed genes (DEGs) compared to Naïve and Resolved USCs, respectively (Fig.
S1A-B). In contrast, no DEGs were detected between Resolved and Naïve USCs. 40 genes were
differentially expressed in Sensitized USCs compared to both Naïve and Resolved USCs, and the
top 15 DEGs including glutathione transferase genes, Mgst1 and Mgst3 are listed (Fig. 3H). Both
the epigenomic and transcriptomic analysis of USCs suggest that Sensitized mice have heritable
changes to their USCs that are evident when grown under stem cell culture conditions.

To investigate which transcription factors (TFs) are involved in altered gene regulation,
enrichment of known binding motifs in Sensitized-accessible and Resolved-accessible DARs were
analyzed. I found that Sensitized-accessible DARs are highly enriched for binding motifs of
inflammation and apoptosis-related TFs, including SOX10, BATF, EHF, and RUNX2, while
Resolved-accessible DARs are highly enriched for motifs of the AP-1 family TFs, which are
known to be induced by pro-inflammatory cytokines (Fig. S3A-B). A putative gene regulatory
network was constructed by directly linking TFs and their target genes in Sensitized cells (Fig.
S3C). In this putative regulatory network, the TFs, including SOX family, AP-1 family, EHF
family, and RUNX2, coordinate the expression of genes involved in inflammatory response and
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programmed cell death regulation, including Gdf15, Casp1/4, Card14, and Aspa, while AP-1 and
EHF family TFs also have SOX10 motifs at their promoter sites. This indicates that Sensitized
USCs are more prone to initiate these gene expression pathways upon inflammation or infection.

3.3.3 USC lines from mice with different disease histories express different
differentiation programs
I next assessed the differential gene expression in response to infection of differentiated urothelia.
USCs were differentiated on Transwells for 2-3 weeks in vitro as described above (Chapter 2) and
then infected with a prototypical UPEC strain, UTI89, or mock-infected with PBS for 2 hours at
which time RNA was harvested for RNA-seq and transcript analyses. PCA of all DEGs showed
that the transcriptional profiles of mock-infected differentiated urothelia were clustered by the
infection history of USCs (Fig. 4A), indicating intrinsic differences in the differentiated urothelia
due to prior infection history, in line with what was observed in USCs (Fig. 3G). Differentially
expressed genes between mock-infected Sensitized and Resolved differentiated urothelia were
visualized in a volcano plot (Fig. 4B). However, infection largely caused a uniform shift in the
PCA plot for each cell line (Fig. 4A), likely reflecting a largely conserved transcriptional response
to UPEC infection in each convalescent state (Fig. S4A). To further investigate transcriptional
differences between cell lines, I performed Ingenuity Pathway Analysis (IPA) using DEGs
comparing mock-infected Sensitized and Resolved differentiated urothelia (Fig. 4C). Sensitized
and Resolved differentiated urothelia displayed differential gene expression in pathways related to
apoptosis, reactive oxygen species (ROS) response, and immune response independent of UPEC
infection (Fig. 4C, S4B-C). Pathway analysis of these genes comparing UTI89 vs. mock infection
for each cell line revealed enrichment for similar pathways including iNOS signaling, HMGB1
signaling, IL-1 signaling, and dendritic cell maturation pathways (Fig. S5A). Venn diagram of
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these enriched pathways for Naive, Resolved, and Sensitized urothelia showed that changes in 44
upregulated and 13 downregulated pathways are shared between all cell lines upon infection,
demonstrating conserved core urothelial response to UPEC infection in all cell types (Fig. S5CD). In addition, analysis showed that Sensitized urothelial had unique changes in pathways (34
upregulated and 23 downregulated) including upregulated TGF β signaling, NRF2-mediated
oxidative stress response, and retinoic acid mediated apoptosis signaling pathways (Fig. S5C-D).

Based on our in vivo observations that the remodeled Sensitized urothelium response to
UPEC infection is characterized by severe exfoliation and Cox-2 inflammation-dependent mucosal
wounding (6), I specifically interrogated pathways that are related to the inflammatory cell death.
A heatmap of gene expression shows that genes associated with programmed cell death pathways
are more enriched in Sensitized differentiated urothelia compared to Resolved differentiated
urothelia (Fig. 4D, Data S2), while Casp1 is the most significantly differentially regulated gene
between Sensitized and Resolved differentiated urothelia according to IPA (Table S2). Pyroptosisrelated genes, including Aim2, Casp1, and Gsdmc2/3, were all upregulated in Sensitized
differentiated urothelia while apoptosis and necroptosis-related genes were upregulated in
Resolved differentiated urothelia compared to the other cells, suggesting that these cells have
different programmed cell death mechanisms during UPEC infection. Consistent with our previous
in vivo studies, which showed bladder remodeling after a prior infection, these data indicate the
presence of an epithelial-intrinsic memory of infection.
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3.3.4 Sensitized differentiated urothelia are reprogrammed to express
increased levels of Caspase 1, revealing a mechanism of epithelial-intrinsic
trained immunity
RNA-seq fold-changes did not generally correspond well with local ATAC-seq fold-changes (Fig.
S6A-B). This may be in part because accessible chromatin regions distal to the associated genes
may or may not be acting to enhance the transcription of those genes and that differentiation is
likely to change chromatin structure and accessibility. However, increased chromatin accessibility
directly at gene promoter regions will better identify TF binding sites that facilitate gene
transcription. To focus on changes at the promoter sites, I selected DAR-neighboring genes whose
promoter sites are located within 5 kb of DARs, then collected overlapping genes from Sensitizedenriched or Resolved-enriched DEGs (Fig. 5A). I found that inflammatory response related genes
including Casp1 and Gdf15 showed highly positive correlations between chromatin accessibility
proximal to their promoters and gene expression, which suggest that these inflammatory sensor
genes are primed upon initial chronic infection and may allow faster response to secondary
infection (Fig. 5A-B).
In mouse and human, Caspase 1 and Caspase 4 (Caspase 11 in mouse, encoded by the
Casp4 gene) have been shown to be involved in pyroptotic cell death, although Caspase function
may vary depending on cell or stimulus type (14, 15). Here I found that Casp1 and pyroptosis
related genes were more highly expressed in Sensitized differentiated urothelia (Fig. 4F), and
chromatin accessibility of the Casp1 promoter region was also highly increased in Sensitized USCs
compared to Resolved USCs (Fig. 5A-B). To validate differential gene expression of Casp1, I
performed RT-qPCR using differentiated urothelia. As I observed in the RNA-seq of differentiated
urothelia, Casp1 was more highly expressed in Sensitized differentiated urothelia compared to
Resolved, independent of UPEC infection (Fig. 5C). In contrast, Casp4 genes were similarly
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induced by UPEC infection in all cell lines (Fig. 5C). Concordantly, immunoblot staining showed
that only Sensitized differentiated urothelia expressed Caspase 1 (Fig. 5D), in agreement with our
previous ex vivo proteomics of convalescent Sensitized mouse bladders (9), which demonstrated
that Caspase 1 is enriched in Sensitized relative to Resolved urothelium.
In our previous studies, we found that the secreted pore-forming bacterial toxin αhemolysin (HlyA), commonly produced by UPEC, induces Caspase 1/11-dependent
inflammasome-mediated cell death in human and mouse urothelial cells (14). HlyA expression is
normally tightly regulated by the CpxRA two-component system, but hlyA overexpression in a
cpxR deletion mutant induces robust urothelial exfoliation and reduced bacterial burdens.
Inhibition of Caspase 1/11 restored virulence of the HlyA overexpressing UPEC strain,
demonstrating that Caspase 1-mediated pyroptotic cell death is protective against UPEC infection
(14). Based on this in vivo evidence, I hypothesized that enhanced Caspase 1 expression in the
Sensitized differentiated urothelium leads to a more robust pyroptotic cell death response upon
wild type (HlyA+) UPEC infection in vitro. An LDH cytotoxicity assay demonstrated that UPEC
infection induced cell death in Naïve, Resolved, and Sensitized differentiated urothelia (Fig. 5E),
but cell death was much greater in Sensitized differentiated urothelia. I next performed challenge
infections using WT UTI89 and UTI89ΔhlyA strains in Naïve, Resolved and Sensitized mice. At
6 hpi, ΔhlyA infection showed significantly increased bacterial burdens in Sensitized mice
compared to wild type, whereas there were no differences in Naïve and Resolved mice (Fig. 5F).
I also extended the length of the secondary challenge infection to 28 days to investigate phenotypic
differences in disease outcome. The incidence of recurrent chronic cystitis at 28 dpi was
significantly increased in Sensitized mice when infected with UTI89ΔhlyA compared to those
infected with WT UTI89. Naïve mice are generally less susceptible to chronic cystitis as they age
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and there was no difference in the overall low incidence of chronic cystitis in Naïve mice infected
with UTI89ΔhlyA compared to those infected with WT UTI89 (Fig. 5G). Resolved mice did not
develop recurrent chronic cystitis with either bacterial strain, in accordance with their previously
established resistance to rUTI. These findings indicate that Caspase 1 overexpression in Sensitized
urothelial cells is a protective response that helps to resolve challenge UPEC infection, revealing
an epithelial-intrinsic mechanism of trained immunity.

3.4 Discussion
Previous studies have shown that bladder tissue adaptation (bladder remodeling) in response to
UPEC infection renders the bladder overall either more susceptible to or resistant to secondary
infection, depending on prior infection outcomes (Fig. 6A-D) (5-7). I hypothesized that this altered
susceptibility was mediated, at least in part, by the development of trained immunity of the bladder
mucosa. In contrast with adaptive immunity, which encompasses antigen-specific responses by T
and B lymphocytes, “trained immunity” is characterized by non-specific tissue adaptation to acute
and chronic inflammation, sometimes in response to infection, and has been predominantly studied
in professional immune cells, such as macrophages, monocytes, dendritic cells, and natural killer
cells (16-18). However, the long-lasting bladder remodeling phenotypes and other morphological,
transcriptional, and functional changes seen in mice previously infected with UPEC suggested the
possibility that epithelial stem cells were being reprogrammed as a mechanism of trained
immunity.

Here I used a primary epithelial cell culture system (19) to study the urothelial-intrinsic
contribution to bladder mucosal remodeling. Strikingly, I found that urothelial remodeling changes
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observed in previously infected mice could be recapitulated in vitro by differentiating the
respective USC lines. Furthermore, I detected differences in USC chromatin accessibility that
segregated by disease history, thus providing an epigenetic mechanism of these long-lasting
phenotypes. Lastly, while the USCs displayed few examples of differential gene expression
between the different disease histories, I observed broad differential gene expression upon
differentiation, particularly with regard to urothelial cell death. The mechanism of differential gene
expression in differentiated urothelia originating from the different USC lines likely involves
differentiation-induced TF binding to open promoter sites within these differentially accessible
regions (Fig. 6E-F).

The bladder urothelium of previously infected mice is known to be resistant to intracellular
colonization relative to age-matched Naïve mice (6, 7). However, the mechanisms for this differs
between Resolved and Sensitized mice. In Resolved mice, UPEC initially form intracellular
bacterial communities (IBCs) in the urothelial cells, but they are rapidly shed within the first 6
hours of infection via enhanced TNFα-mediated inflammation (7). In contrast, IBCs do not form
at all in Sensitized urothelium in vivo, likely due to the small cell size and actin-gating of the
incompletely differentiated superficial cells (6, 20). In this work, I have further illuminated this
protective response by elucidating how the Resolved and Sensitized urothelia are differentially
reprogrammed with regard to the basal levels of expression of cell death machinery components
(Fig. 6G). Our data suggest that HlyA-mediated cell death, which results in urothelial exfoliation,
plays a protective role in reducing bladder colonization in Sensitized bladders. This effect is likely
a consequence of the increased baseline expression of Caspase 1 and other inflammasomeassociated factors, such as Gasdermins C2 and C3 that can act as terminal effectors of
inflammatory cell lysis (21), effects observed here in vitro and previously described in ex vivo
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proteomics studies of mouse urothelia (9). Expression of Aim2, which encodes a cytosolic innate
immune sensor that can activate the Caspase 1 inflammasome, was also more highly expressed in
Sensitized differentiated urothelia. In the skin of mice, epigenetic modification of the Aim2 locus
after a primary insult and resulting inflammation enables the skin to have a more rapid response
to a secondary inflammatory insult (22), suggesting that epigenetic reprogramming of
inflammasome components may be a common mechanism for priming inflammation sensors to
prepare for secondary exposure.

Thus, we have delineated mechanisms of epithelial-intrinsic trained immunity in the
bladder of Sensitized mice that are protective against rUTIs (5-7). However, it is important to note
that Sensitized mice have competing protective and sensitizing responses to challenge infection,
which typically manifests as an extreme bimodal distribution of infection burdens (5). As such,
this protective trained immunity in Sensitized urothelium is nevertheless often overcome by Cox2 inflammation-dependent mucosal wounding that occurs later during acute rUTI at the basal
urothelial cell level, thereby transforming the colonization landscape in favor of the bacteria (6,
9). The activities of Cox-2 and downstream eicosanoid synthetic machinery and effectors are
closely linked to the level of oxidative stress within the cell. Interestingly, I found that Sensitized
differentiated urothelia had evidence of increased expression of factors associated with
glutathione-mediated detoxification pathways relative to Resolved differentiated urothelia (Fig.
4C). However, RNA-seq of Sensitized USCs demonstrated reduced expression of these same
factors, particularly of enzymes that detoxify oxidative radicals such as microsomal glutathione Stransferase 1 (Fig. 3H, S3C-D), which resembles ex vivo proteomics of the Sensitized urothelium
(9). Decreased levels of these protective enzymes, particularly at the stem cell level of the
urothelium where Cox-2 expression is greatest during UPEC infection (9), could explain why
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Sensitized urothelia are so prone to severe mucosal wounding during UPEC infection in vivo,
leading to overwhelming bacterial colonization.

Our discovery of epithelial stem cell chromatin reprogramming upon UPEC infection has
implications for understanding the mechanism of epithelial-intrinsic trained immunity against
other types of infection or inflammatory disease. Our study suggests that further mechanistic
studies of chromatin remodeling in epithelial stem cells may lead to novel therapies for a range of
recurrent infections and inflammatory conditions in various systems. For example, in skin cancer,
therapeutic use of an inhibitor of histone demethylase LSD1, which is overexpressed in skin
epithelial cancer, drives significant increases in H3K4 methylation in the cells thus leading to both
premature epidermal differentiation and the repression of squamous cell carcinoma (23). Further
investigation into DNA methylation, acetylation, and histone modification responses to infection
and how this differs with UPEC infection outcome could shed light on potential therapeutic targets
to prevent rUTIs and/or reverse the epigenetic remodeling that leads to increased susceptibility to
recurrent disease. Overall, our findings of epithelial-intrinsic trained immunity against UTIs
demonstrate an essential contribution of epithelial stem cells to bladder remodeling and subsequent
differential susceptibility to recurrence, which fills a gap in knowledge of the pathophysiology of
rUTIs.
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3.5 Figures and Tables

Fig. 1. Scheme of 3D primary cell culture and 2D Transwell culture system. USCs isolated
from 8 week old C3H/HeN mice are expanded by spheroidal culture in matrigel with 50% L-WRN
conditioned media (CM) including Y27632, ROCK inhibitor, and SB431542, TGF β type 1
inhibitor. After 3 days of spheroid culture, cells are dissociated into a single cell suspension and
3-4x105 cells were seeded onto the Transwell membrane. Once they start increasing TER values
up to 600 ohm*cm2, cells were cultured in 5% CM to differentiate the urothelium for 2-3 weeks
until they reach to their maximum TER value, 4000 ohm*cm2. Then the differentiated urothelium
on Transwell can be used for UPEC infection assay.
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Fig. 2. Differentiated urothelia originating from previously infected mice maintain bladder
remodeling phenotypes. (A) Time course of initial infection with 108 cfu UTI89 KanR and
convalescent period in C3H/HeN mice and (B) representative urine bacterial titer time course over
4 wpi. Dashed horizontal line represents the cutoff for significant bacteriuria: 104 cfu/ml. Naïve,
Resolved and Sensitized mice were named as N1-4 (blue), R1-4 (orange), and S1-4 (purple). (CD) USCs isolated from these mice were cultured into differentiated urothelium on Transwells,
fixed and imaged via (C) confocal microscopy and (D) SEM. In (C) the urothelia were stained for
F-actin (Phalloidin), CK20, E-cadherin, and nuclei (DAPI). (E) Transwells were paraffinembedded, sectioned and immunostained for UPK3A, E-cadherin, and nuclei. White arrows show
cell junctions indicating size of surface cells. (F-G) Fixed slides processed from 44 Transwells of
Naïve, Resolved, and Sensitized (n=16, 12, and 16 Transwells from n=4, 3, 4 mice, respectively)
were stained for CK20, E-cadherin, and nuclei, labeled and imaged in a double-blind manner. Then
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the superficial cell sizes were automatically measured using the Fiji ImageJ macro program and
plotted for (F) average cell size per each Transwell and (G) individual cell size, represented as
median with 95% CI.
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Fig. 3. Convalescent mouse USCs have differential chromatin accessibility near
inflammatory response genes. Omni-ATAC-seq was performed using USCs of Naïve, Resolved,
and Sensitized cells (cell lines N1, N3, R1, R4, S1, and S2, each from an individual mouse).
Differentially accessible regions (DARs) across the USC cell lines are shown as (A) a PCA plot,
and significantly differential peaks (FDR <0.05) comparing Sensitized vs. Resolved USCs are
shown as (B) a volcano plot. The top 20 of Sensitized vs. Resolved DARs are indicated as number
1 to 20 on the graph. (C) Out of all 2880 DARs, 925 regions are Sensitized-accessible DARs and
1955 regions are Resolved-accessible DARs. (D) Average ATAC-seq signals are plotted over 10
kb regions centered on the DARs. (E-F) Top 15 enriched GO terms for (E) Sensitized (fold change
>1.5, FDR <0.05) and (F) Resolved-enriched DAR (fold change <-1.5, FDR <0.05) are analyzed
using GREAT. (G) RNA-seq was performed using USCs of Naïve, Resolved, and Sensitized cells
(cell lines of N1-4, R1-4, S1, and S3-4 from an individual mouse). Differentially expressed genes
(DEGs) across the USC cell lines are shown as PCA plot. (H) The Venn diagram shows 40 DEGs
that overlapped between Sensitized vs Naïve and Sensitized vs Resolved, and the top 15
overlapping DEGs are listed.
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Fig. 4. Differentiated urothelia originating from convalescent mice maintain differential
transcriptomics observed in vivo. RNA was isolated from Naïve, Resolved, and Sensitized
differentiated urothelia with or without UPEC infection at 2 hpi (n=8, 10, and 12 from cell lines
of N3, R3, and S3, respectively), then analyzed by RNA-seq to assess differential gene expression.
(A) The PCA of DEGs shows clustering by cell lines (prior infection outcome) and secondary
infection condition. (B) A volcano plot comparing mock-infected Sensitized vs. Resolved
differentiated urothelial is shown. (C) Pathway analysis was used to assess the biological pathways
enriched in differentially expressed genes in mock-infected Sensitized relative to Resolved
differentiated urothelia, and significance was determined by a right-tailed Fisher’s exact test, with
P-adjusted <0.05 considered significantly enriched pathways. Shown are selected pathways with
z-score > 2 and –log(p-value) > 4.2 from the specific enriched pathways by Ingenuity IPA. (D)
The heatmap shows programmed cell death associated genes which are differentially expressed in
mock-infected Naïve, Resolved, and Sensitized differentiated urothelia.
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Fig. 5. Increased Caspase 1-mediated inflammatory cell death in Sensitized USCs protects
Sensitized mice from acute and chronic UPEC infection. (A) Promoter-closed genes meeting
indicated cut-offs were selected to find a correlation with the DEGs of Sensitized differentiated
urothelia with or without infection. (B) ATAC-seq signals of Casp1 and Gdf15 were visualized
using the WashU epigenome browser map and fold change gene expressions (USCs and
differentiated urothelial cells [DUCs]) of Casp1 and Gdf15 were plotted. (C) Casp1 and Casp4
gene expression in differentiated urothelia was measured by RT-qPCR (data are represented as
mean ± SD) and (D) protein expression of Caspase 1 was assessed by western blot. (E) Cell death
of differentiated urothelia 4 hours after UTI89 infection was measured with a lactate
dehydrogenase (LDH) assay. Data are represented as mean ± SD and significance was determined
with a one-way ANOVA. (F-G) Naïve, Resolved, and Sensitized mice were challenged with 107
cfu of WT UTI89 (HlyA+) or UTI89ΔhlyA. (F) Urine bacterial burden at 6 hpi and (G) incidence
of chronic cystitis at 28 dpi are shown. Data are combined from two to three independent
experiments. (F) Bars indicate median values and Mann–Whitney U test was used to determine
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significance. (G) Fisher’s exact test was used to determine significance and the number of mice is
indicated on the graph. *P < 0.05.
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Fig. 6. Model for bladder epithelial stem cell remodeling and trained immunity. (A) 8 week
old C3H/HeN mouse urothelium is fully differentiated with hexagonal and often binuclear
superficial facet cells. (B) UPEC infected urothelium exhibiting? chronic cystitis with bladder
hyperplasia, inflammation and exfoliation. (C) After antibiotic treatment, the bladder regenerates
the urothelium. However, bladders with a history of chronic cystitis are remodeled, with smaller
superficial facet cells, defects in cell differentiation, and altered gene expressions related to cell
death and immune response. (D) Bladder remodeling (Sensitization) also affects the urothelial
response upon secondary infection predisposing it to higher susceptibility to rUTIs. (E) Sensitized
USCs have epigenetic changes in chromatin structure which are associated with their bladder
remodeling phenotypes. More open TF binding sites at Casp1 and Mgst2 promoters can explain
altered cell death and inflammatory response in Sensitized cells, while more closed TF binding
sites at Upk3a and Acta1 promoters might be related with differentiation defects and abnormal
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actin remodeling in Sensitized cells. (F) During secondary UPEC infection, epigenetic changes in
Sensitized urothelia can be beneficial to the bladder. AKT downregulation and differentiation
defects prevent UPEC invasion and IBC formation. Casp1/4 mediated pyroptotic cell death causes
massive exfoliation and leads to clearance of bacteria during early UPEC infection. (G) Model for
trained immunity in epithelial stem cells upon an initial inflammatory insult and different memory
responses of Resolved and Sensitized USCs depending on different epigenetic memories.
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Fig. S1. Infection of Naïve, Resolved, and Sensitized differentiated urothelia revealed
differential cytokine expressions. Differentiated urothelia were infected with UTI89 at MOI 50
for 4 hours then the presence of 23 mouse cytokines were analyzed in apical medium by a Luminalbased multiplex cytometric bead array (Bioplex). Expressions of IL-6, G-CSF, and CXCL1 (KC)
were increased upon UTI89 infection, while RANTES expression is suppressed in Resolved and
Sensitized differentiated urothelia compared to Naïve differentiated urothelia independent to
UPEC infection. Each condition has two biological replicates.
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Fig. S2. RNA-seq of primary USCs originated from convalescent mice revealed that
sensitized USCs maintain differential gene expressions after several passages, related to Fig.
3. RNAs were isolated from Naïve, Resolved, and Sensitized USCs, then analyzed by RNA-seq
and performed differential analysis. 108 and 73 genes were significantly differentially expressed
in Sensitized USCs relative to (A) Naïve and (B) Resolved USCs (P-adj < 0.05). Enriched
pathways in Sensitized compared with (C) Naïve and (D) Resolved USCs are listed here.
Overlapping pathways in both analyses are underlined, which are related with apoptosis, ROS
response, and immune response.
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Fig. S3. Enriched known motifs of Sensitized and Resolved-specific DARs, related to Fig. 3.
ATAC-seq data in Fig. 3 were used to here as well. Enriched TF binding motifs in DARs and their
hypergeometric p-values from HOMER. Sequence logo of each (A) known and (B) de novo motifs
are shown on the left. (C) The putative gene regulation networks in Sensitized USCs are
constructed based on motif annotation data and known interactions. Arrows indicate the
interactions between TFs and target genes. The genes in bold are known to be related to apoptosis
and inflammatory signaling.
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Fig. S4. Differential transcriptomics of differentiated urothelia originating from
convalescent mice recapitulate in vivo studies, related to Fig. 4. RNA-seq data of UTI89
infected and mock-infected differentiated urothelia was used here to perform differential analysis.
(A) Volcano plot comparing UPEC infected vs. mock-infected Naïve, Resolved, and Sensitized
differentiated urothelia (UPEC infection response). (B) Volcano plot comparing UPEC infected
Sensitized vs. Resolved differentiated urothelia was performed. (C) Pathway analysis was used to
assess the biological pathways enriched in differentially expressed genes in UPEC infected
Sensitized differentiated urothelia relative to Resolved differentiated urothelia, and significance
was determined by a right-tailed Fisher’s exact test, with P-adjusted <0.05 considered significantly
enriched pathways. Shown are selected pathways with z-score > 2 and –log(p-value) > 2 from the
specific enriched pathways by Ingenuity Pathway Analysis (IPA).
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Fig S5. Pathway analysis of differential transcriptomics of differentiated urothelia, related
to Fig. 4. RNA-seq data of UTI89 infected and mock-infected differentiated urothelia was used
here to perform differential analysis. (A) DEGs comparing UPEC infected and mock-infected
Naïve, Resolved, and Sensitized urothelia were used for Ingenuity pathway analysis to show the
enriched pathways of Naïve, Resolved, and Sensitized urothelia upon UPEC infection. Venn
diagram of (B) upregulated and (C) downregulated pathways upon infection in Naïve vs. Resolved
vs. Sensitized urothelia. (B) 34 pathways that are exclusively enriched in UTI89 infected
Sensitized urothelia and (C) 23 pathways that are exclusively less enriched in UTI89 infected
Sensitized urothelia are indicated in the box.

81

Fig. S6. Global correlation analysis of RNA-seq and ATAC-seq summary statistics showed
no significant correlation between transcriptomics and chromatin structures, related to Fig.
5. Correlation analysis of ATAC-seq DARs and RNA-seq DEGs were performed using fold
changes of Sensitized vs. Resolved for both DARs and DEGs. (A) Global correlation analysis
using all genes are plotted. (B) Relative fold changes of RNA-seq of each mock-infected and
UPEC infected are shown. Log2 (RNA fold change) are close to dashed horizontal line, indicating
that there is no specific direction of correlation (positive or negative).
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Table S1
REAGENT or RESOURCE

SOURCE

IDENTIFIER

mouse monoclonal anti-Uroplakin 3a
(UPK3A)

Fitzgerald

10R-U103a

mouse monoclonal anti-Cytokeratin 20
(CK20)

DAKO

M7019

goat polyclonal anti-E-cadherin (Ecad)

R&D Systems

AF748

rabbit polyclonal anti-Trp63

GeneTex

GTX102425

chicken polyclonal anti-Cytokeratin 5 (CK5)

BioLegend

905901

4′,6-diamidino-2-phenylindole (DAPI)

ThermoFisher

D1306

Alexa Fluor 555 Phalloidin

ThermoFisher

A34055

mouse monoclonal anti-Caspase-1 (p20)

AdipoGen

AG-20B-0042-C100

Rabbit monoclonal anti-Caspase-11

Abcam

ab180673

beta Actin Loading Control Monoclonal
Antibody (BA3R)

Invitrogen

MA5-15739

UTI89 pANT4

(24)

UTI89

UTI89 attHK022::COM-GFP

(25)

UTI89-KanR

UTI89 hlyA::KD13

(14)

UTI89 ∆hlyA (KanR)

Antibodies

Bacterial and Virus Strains

Chemicals, Peptides, and Recombinant Proteins
Y-27632

R&D System

1254

SB431542

R&D System

1614

Corning Matrigel Matrix

BD Biosciences

356234

DMEM/F12 with HEPES

Sigma-Aldrich

D6421
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DMEM high glucose

Sigma-Aldrich

D6429

Advanced DMEM/F12

Invitrogen

12634028

FBS

Sigma-Aldrich

F6178

Transwell polyester membrane inserts

Corning

CLS3470-48EA

IGEPAL CA-630

Sigma-Aldrich

I8896

Phusion High-Fidelity DNA polymerase

New England
BioLabs

M0530S

Agencourt AMPure XP

Beckman Coulter

A63880

0.2ml PCR strip magnetic separator stand

Permagen

MSR812

Tapestation tube 0.2 ml PCR tube strips

Fisherbrand

14230210

High Sensitivity D1000 screentape (7 strips)

Agilent

5067-5584

High Sensitivity D1000 reagents

Agilent

5067-5585

High Sensitivity D1000 sample buffer

Agilent

5067-5603

Agilent 4200 Tapestation system

Agilent

G2991AA

RNeasy mini kit

QIAGEN

74104

LDH Cytotoxicity Detection kit

TaKaRa Bio

MK401

Pierce Rapid Gold BCA Protein Assay Kit

ThermoFisher

A53227

Nextera DNA Sample Preparation Kit

Illumina

FC-121-1030

MinElute PCR Purification Kit

QIAGEN

28004

iScript Reverse transcription supermix

Bio Rad

1708841

iTaq Universal SYBR green Supermix

Bio Rad

1725121

Qubit dsDNA HS Assay Kit

ThermoFisher

Q32851

Critical Commercial Assays

Deposited Data
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RNA-seq sequencing data for Adult Naïve,
Resolved, and Sensitized USCs

This paper

NCBI BioProject ID no.
PRJNA705407

RNA-seq sequencing data for Adult Naïve,
Resolved, and Sensitized differentiated
urothelia

This paper

NCBI BioProject ID no.
PRJNA705407

ATAC-seq sequencing data for Adult Naïve,
Resolved, and Sensitized USCs

This paper

NCBI BioProject ID no.
PRJNA705407

Experimental Models: Cell Lines
Mouse: C3H/HeN: 8 weeks old juvenile
naïve (J1-5)

This paper

Mouse: C3H/HeN: Adult Naïve (N1-4)

This paper

Mouse: C3H/HeN: Resolved (R1-4)

This paper

Mouse: C3H/HeN: Sensitized (S1-4)

This paper

Human: 5637 bladder epithelial cells

ATCC

HTB-9 TM

L-WRN cell

ATCC

CRL-3276TM

Envigo

C3H/HeN Hsd

Primer: Trp63 Forward

This paper

TACTGCCCCGACCCT
TACATCC

Primer: Trp63 Reverse

This paper

ATATGCTGGAAGACC
TCTGGGCT

Primer: Axin2 Forward

This paper

AAGAGAAGCGACCC
AGTCAATCC

Primer: Axin2 Reverse

This paper

GGTTCCACAGGCGTC
ATCTCC

Primer: Upk3a Forward

This paper

TCAGCGGCTCTTACG
AGGTTTAC

Experimental Models: Organisms/Strains
Mouse: C3H/HeN: rUTI model
Oligonucleotides
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Primer: Upk3a Reverse

This paper

GACCTCCCACCCTGG
GTTTG

Primer: Casp1 Forward

This paper

CCCACTGCTGATAGG
GTGAC

Primer: Casp1 Reverse

This paper

GCATAGGTACATAAG
AATGAACTGGA

Primer: Casp4 Forward

This paper

TGTCATCTCTTTGATA
TATTCCTGAAG

Primer: Casp4 Reverse

This paper

CAAGGTTGCCCGATC
AAT

Software and Algorithms
cutadapt-v1.6

v1.6

tophat2-v2.0.11

v2.0.11

bowtie2-2.2.2

2.2.2

HTSeq-v0.6.0

v0.6.0

Salmon_0.8.2

v0.8.2

DESeq2_1.14.0

1.14.0

Ingenuity Pathway Analysis

Qiagen
Bioinformatics

RRID:SCR_008653

Fastqc v0.11.5

v0.11.5

Cutadapt v1.11

v1.11

Samtools v1.5

v1.5

Bowtie2 v2.3.0

v2.3.0

picard v2.10.0

v2.10.0

Macs2 v2.1.1.20160309

v2.1.1.20160309

bedtools v2.26.0

v2.26.0
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HOMER

(26)

http://homer.ucsd.edu/ho
mer/

GREAT

(13)

http://great.stanford.edu/p
ublic/html/

Fiji ImageJ

(27)

doi:10.1038/nmeth.2019

Table S1. Key resources and reagents used in this study.
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Table S2

Expr Log Ratio (up)

Expr Log Ratio (down)

Molecules

Value

Molecules

Value

Casp1

6.814

Igf2bp1

-7.498

Gypc

6.592

Olfm4

-6.513

Akr1e2

6.349

Prl2c2 (includes others) -5.431

Gdf10

6.336

Itga7

-5.298

Rgs9bp

5.604

Ccl5

-5.156

Krt17

5.204

S100a9

-4.553

Ugt8

5.136

A430010J10Rik

-4.460

Stfa1 (includes others)

4.987

Fam221a

-4.342

Ddit4l

4.912

Spp1

-4.340

Adamts5

4.912

Duox2

-4.262

Table S2. Top analysis ready molecules from IPA comparing mock-infected Sensitized vs.
Resolved differentiated urothelia. “Exp Log Ratio” indicates expression log2 fold change.
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3.6 Materials and Methods
Ethics statement
All animal experimentation was conducted according to the National Institutes of Health
guidelines for the housing and care of laboratory animals. All experiments were performed in
accordance with institutional regulations after review and approval by the Animal Studies
Committee at Washington University School of Medicine in St Louis, Missouri.
Mouse infections
Female C3H/HeN mice were obtained from Envigo (Indianapolis, IN). All mice were seven to
eight weeks old (‘juvenile’) at the time of the initial infection. For the initial infection, a total 108
cfu of bacteria were inoculated into the bladder of C3H/HeN mice by transurethral catheterization
as previously described (28). C3H/HeN mice develop chronic cystitis in an infection doesdependent manner and this inoculum results in chronic cystitis in ~50% of mice (6). To monitor
infection outcomes, urine was collected at 1, 3, 7, 10, 14, 21, and 28 days post-infection (dpi) (5).
As we previously defined, 104 cfu/ml persistent bacteriuria is a specific and sensitive cutoff for
detecting chronic cystitis (5). Chronic cystitis during initial infection was defined as persistent
high bacteriuria (>104 cfu/ml urine) at every time urine was collected, while resolution of cystitis
was defined as urine bacterial titer dropping below the cutoff (104 cfu/ml urine) at least one time
point.
At four weeks post-infection, all mice were treated with trimethoprim and sulfamethoxazole in the
drinking water for 10 days (54 and 270 μg/ml water, respectively) (6). Urine samples were
collected weekly after the initiation of antibiotics to confirm clearance of bacteriuria. Four weeks
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after the initiation of antibiotics, these convalescent mice (Naïve, Resolved, and Sensitized mice)
were used to isolate primary urothelial stem cells (USCs) or used for secondary infection assay.
For the secondary infection, mice were challenged with 107 cfu of bacteria inoculated into the
bladders as described above. To assess acute outcomes, mice were humanely euthanized 6-hour
post-challenge and bacterial burdens were determined as described above.
Bacterial strains
The UPEC strain primarily used in this study was a kanamycin-resistant derivative of the human
cystitis isolate UTI89 (24): UTI89 attHK022::COM-GFP (UTI89-KanR) (25). For enumeration of
intracellular bacteria by epifluorescence microscopy, I used UTI89 pANT4, which contains a
plasmid that constitutively expresses eGFP. For both mouse and in vitro infection, UPEC strains
were cultured statically in lysogeny broth (LB) at 37 °C. UTI89 inocula were prepared as
previously described by spinning down the cultures at RT for 10 min at 3000 g, resuspended in 10
ml PBS, and diluted to approximately 2-3x109 cfu/ml (OD600 = 3.5) (5).
Host cell culture
Human BECs, designated 5637 (ATCC HTB-9) cells, were obtained from the American Type
Culture Collection and maintained in RPMI 1640 supplemented with heat-inactivated 10%
(vol/vol) FBS at 37 °C in the presence of 5% CO2.
Primary USC isolation
The primary USC isolation and culture system was adapted and modified from primary intestinal
epithelial cell culture method described in (29). Bladder tissue from 8 weeks old juvenile Naïve
C3H/HeN mice and convalescent mice (Naïve, Resolved, and Sensitized after initial infection and
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antibiotic treatment) were isolated and bisected, incubated in 1 ml of stripping solution at 4 °C for
overnight. The urothelial cells were scrapped off from the bladder tissue using two forceps on
sterilized tissue culture plate. Collected urothelial cells were then spun down at 4 °C at 300 g for
5 min, resuspended in 1 ml of fresh collagenase IV solution, and incubated with rocking at 37 °C
for 20 min. The cells were disaggregated by gentle pipetting, filtrated with 100 µm strainer, washed
with 1 ml of washing media, then cultured in matrigel with 50% CM as described in 3D spheroid
cell culture. Initial culture might contain some non-stem urothelial cells, so the cells were used for
experiments after 10 passages.
3D spheroid cell culture
Primary bladder epithelial cells were isolated, grown, and maintained as 3D spheroid cultures in
Matrigel (BD Biosciences, San Jose, CA) as described in (29). Cells were kept in 50% L-WRN
CM containing 10 mM Y-27632 and 10 mM SB431542 (R&D System, Minneapolis, MN). Media
were changed every 2 days, and cells were passaged every 3 days (1:2-3 split). Spheroids at various
passage numbers were cryopreserved for future use, then thawed when needed as previously
described (29).
Urothelium culture on Transwell
Spheroidal USCs at 3-day 3D culture were recovered from Matrigel by washing in PBS with 0.5
mM EDTA, and then trypsinized in 0.05% Trypsin, 0.5 mM EDTA for 1 min at 37 °C. The trypsin
was then inactivated by adding washing media then spheroids were dissociated by vigorous
pipetting (using a double tip technique). The cells were then filtered through a 40 µm cell strainer
(BD Biosciences) and resuspended in 1 ml of washing media. The Transwells (3413; Corning
Costar, Tewksbury, MA) were coated in PBS with 1:40 Matrigel for 30 min at 37 °C. Then the
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cell numbers were counted using hemocytometer under microscope. 3-4x104 cells in 100 μl of
50% L-WRN CM containing 10 mM Y-27632 (ROCK inhibitor) were seeded on top of the
Transwell insert. An additional 600 μl of 50% CM were added to the apical compartment of the
Transwells. On average, single cell suspensions from three wells of a 24-well spheroid plate were
enough to seed a single Transwell.
Transepithelial electrical resistance (TER) measurements
TER was measured for cells in Transwells using an epithelial volt-ohm meter (World Precision
Instruments, Sarasota, FL). Resistance of the urothelial multilayers was calculated by subtracting
the resistance of the (membrane + media) from the resistance of the (membrane + media + cells).
Each Transwell was measured in triplicate and the average value was taken. This value was then
multiplied by the area of the Transwell membrane (0.33 cm2) to obtain a final value in ohm*cm2
(30).
In vitro UPEC infection assay
When the Transwell is fully differentiated (TER value > 4000 ohm*cm2), the Transwell inserts
were washed in warm DMEM/F12 media for three times and infected with UPEC strains at
intended MOI (1, 5, 10, 50, and 100) or other stimuli. The infected Transwells were incubated at
37 °C for 30 min, changed media containing 100 µg/ml gentamicin to clear the extracellular
bacteria, and cultured for extended time. After infection, luminal and apical media were spun down
at 2000 g at 4 °C for 5 min, froze at -20 °C for analysis if indicated. The Transwells were washed
with sterile PBS then used for various analysis.
Whole-mount confocal staining
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The cells cultured on Transwell or chamber slides were washed and fixed in PBS with 4%
paraformaldehyde (PFA) for 15 min and rinsed three time with PBS. 100 µl of 0.2% Triton-X was
treated for 10 min then dumped, and the cells were incubated in 100 µl of 2% BSA in for blocking
for 30 min. After primary and secondary antibody staining and associated washes, the samples
were stained with Alexa Fluor 555 Phalloidin (Molecular Probes binding to F-actin) and 4′,6diamidino-2-phenylindole (DAPI). The samples were mounted in ProLong Gold Antifade
Mountant (Thermo Fisher), then examined by confocal microscopy on a ZEISS LSM880 Laser
Scanning Microscope with Airyscan. Fiji ImageJ and macro program were used to automatically
calculate epithelial cell surface area in z-stacked confocal images.
Histopathology and immunofluorescence
USC spheroids or urothelium on the Transwells were fixed overnight in 10% formaldehyde at RT
or 4 °C. After wash in PBS, the fixed samples are pre-embedded into 2% agar, cut vertically, put
the Transwell side face up, embedded again in paraffin blocks, and sectioned. The slides were
stained for H&E and immunostained for selected antibodies. For immunofluorescence staining,
slides were deparaffinized, hydrated, blocked with 10% heat-inactivated horse serum (HIHS) and
0.3% triton X-100 in PBS, incubated with primary antibody in 1% HIHS and PBS overnight at 4
°C and secondary antibody in PBS for 30-60 min at RT (6). The primary antibodies used were
uroplakin-3 (mouse monoclonal, 10R-U103a, Fitzgerald), Trp63 (rabbit polyclonal, GTX102425,
GeneTex), E-cadherin (goat polyclonal IgG, AF748, R&D Systems), cytokeratin 5 (chicken
polyclonal, 905901, BioLegend) and cytokeratin 20 (mouse monoclonal, M7019, DAKO). Nuclei
were stained with Hoechst (Thermo fisher). Samples were mounted in ProLong Gold Antifade,
and fluorescence was visualized on a Zeiss Axio Imager M2 Plus wide Field Fluorescence
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microscope. Antibodies are verified at 1DegreeBio (http://1degreebio.org/), except cytokeratin 5
and cytokeratin 20 (verified at manufacturers’ websites) (6).
Scanning electron microscopy
Urothelium on the Transwell inserts were washed 3 times in PBS, fixed in EM fixative (2%
paraformaldehyde, 2.5% glutaraldehyde in 1x PBS) for 1 hour on ice, and washed 3 times in PBS.
Samples were then post-fixed in 1.0% osmium tetroxide, dehydrated in increasing concentrations
of ethanol, then dehydrated at 31.1 °C and 1,072 p.s.i. for 16 min in a critical point dryer (6).
Samples were mounted on carbon tape-coated stubs and sputter-coated with gold/palladium under
argon (6), then they were imaged on a Zeiss Crossbeam 540 FIB-SEM.
RNA isolation and RT-qPCR
Spheroids or cells on the Transwell were treated with reagents or infected with UPEC before RNA
isolation. RNA was extracted using the RNAeasy Plus Mini Kit (Qiagen) and reverse-transcribed
with iScript Reverse Transcription Supermix (BioRad). RT-qPCR for expression of Ptgs2, Casp1,
Casp4, were performed as previously described (9, 14). 1 μl of 12.5 ng/μl cDNA was used with
intron-spanning primers specific to each gene and iQ SYBR Green Supermix was used according
to the manufacturer’s instructions (Bio-Rad). Expression values were normalized to 18S
expression levels, and the expression fold change relative to mock-infected cells or Naïve cells
was determined by the cycle threshold (ΔΔCt) method (31). Each sample was run in triplicate, and
average Ct values were calculated.
RNA-seq and data analysis
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Illumina cDNA libraries were generated using a modified version of the RNAtag-seq protocol (32,
33). Briefly, 1μg of total RNA was fragmented, depleted of genomic DNA, dephosphorylated, and
ligated to DNA adapters carrying 5’-AN8-3’ barcodes of known sequence with a 5’ phosphate and
a 3’ blocking group. Barcoded RNAs were pooled and depleted of rRNA using the RiboZero rRNA
depletion kit (Illumina). A second adapter was added to cDNAs by template switching, cDNAs
were amplified with oligos carrying Illumina P5 or P7 sequences, and the resulting cDNA libraries
were sequenced to generate paired end reads.
Sequencing reads from each sample in a pool were demultiplexed based on their associated
barcode sequence using custom scripts (https://github.com/broadinstitute/split_merge_pl).
Barcode sequences were removed from the first read as were terminal G’s from the second read
that may have been added during template switching. Reads were then trimmed by cutadapt twice
(cutadapt-v1.6), once by base quality and once by polyA or polyT repeats. Trimmed reads were
then aligned to the Mus musculus mm10 genome using tophat2 (34) (tophat2-v2.0.11, bowtie22.2.2). Gene counts were conducted by HTSeq (35) (HTSeq-v0.6.0, options: –format = bam –order
= name –stranded = no –idattr = gene_id –mode = union) and read counts were assigned to
annotated transcripts using Salmon_0.8.2 (7, 36). Differential expression and pathway analysis
were conducted with DESeq2_1.14.0 (37) and Ingenuity Pathway Analysis (IPA), respectively.
ATAC-seq and data analysis
To generate chromatin accessibility profiles for Naïve, Resolved, and Sensitized USCs, OmniATAC libraries were generated as previously described (12). Briefly, 2-3 wells of spheroid
cultures were dissociated to prepare 1-2x105 cells for each sample. After nuclei preparation,
50,000 nuclei were counted and transferred into 25 μl of 2x TD buffer. 25 μl of Omni-ATAC
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ATAC-seq reaction mix including TDE1 enzyme was added to 25 μl of 50,000 nuclei in 2x TD
buffer, then the samples were incubated at 37 °C for 30 min (tapped every 10 min during the
incubation in a heat block). Transposed DNA fragments were immediately purified by using a
MinElute PCR Purification Kit (Qiagen). ATAC-seq libraries were amplified by using 10-12
cycles of PCR amplification with an initial 5-min extension at 72 °C and purified by using AMPure
XP Beads (Beckman Coulter). The purified libraries were eluted with 20 μl of nuclease-free water,
quantified using Qubit dsDNA HS Assay Kit, and their size distribution was checked with 4200
TapeStation (High Sensitivity D1000 ScreenTape and Reagents) to ensure good RNA quality.
Paired-end ATAC-seq libraries were sequenced on an Illumina NextSeq 500 machine, with a total
of ~350 million reads.
ATAC-seq analysis was performed as previously described (38) and used the following tools and
versions: Fastqc v0.11.5, Cutadapt v.1.11, Samtools v1.5, Bowtie2 v2.3.0, picard v2.10.0, Macs2
v2.1.1.20160309, bedtools v2.26.0. Sequencing reads were de-multiplexed by using samplespecific index sequences, quality checked with fastqc, trimmed by using cutadapt, and aligned to
a reference mouse genome (mm10) by using bowtie2 (39) with these parameters: --local -X 2000
--mm. Picard was then used to remove secondary alignment, multiply mapped reads, and PCR
duplicated reads, and peak calling was done with MACS2 (40), with these parameters: -g 1.87e9
--keep-dup all -B --SPMR --nomodel --extsize 73 --shift -37 -p 0.01 --call-summits. Irreproducible
discovery rate (IDR) analysis with two replicates was performed following ENCODE’s guidelines
(41), and ATAC peaks with IDR < 0.05 were chosen as highly reproducible accessible chromatin
regions for further analysis. The ATAC-seq signals were visualized on the WashU Epigenome
Browser map (42) as fold change over background using bedGraph tracks generated using the
MACS2 bdgcmp function with this parameter: -m FE.
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To identify differentially accessible regions (DARs), Diffbind v2.10.0 (43) was used on the set of
ATAC peaks (IDR < 0.05) with these parameters: fragmentSize = 1, summits = 0. ATAC peaks
with FDR < 0.05 were considered as significantly differentially accessible regions and used for
generating a volcano plot and heatmap comparing Sensitized and Resolved samples. Signal
profiling of these ATAC peaks (FDR <0.05) along with their neighboring regions were performed
using deeptools (44). Functional annotation of peaks (GO biological process) and peak-gene
association were done with GREAT using the default “basal plus extension” parameter (13).
Sensitized (fc > 1.5) and Resolved-specific DARs (fc < -1.5) were separately analyzed and top 15
enriched pathways were shown in Fig. 4G-H. Motif enrichment analysis in DARs was performed
using HOMER tool (26). HOMER scans the sequences of DARs for known motifs including
HOMER-provided motif library and JASPAR core vertebrate motifs and calculates enrichment
score p-values using hypergeometric test. Top 10 of each known and de novo motifs are shown in
Fig. S3, and the motif annotation data was used to predict the putative gene regulation networks.
Immunoblotting
Cells were lysed with cell lysis buffer (9803S, Cell Signaling) according to the manufacturer’s
instructions. Rapid Gold BCA protein assay kit was used to determine protein concentrations in
the cell lysate (A53225, Thermo Scientific). Equal amounts of protein were separated by SDSPAGE and transferred to a nitrocellulose membrane. Membranes were incubated overnight with
antibodies against Caspase 1 (AG-20B-0042-C100, AdipoGen) and β-actin (MA5-15739,
Invitrogen). Corresponding secondary antibodies conjugated with horseradish peroxidase in
combination with enhanced chemiluminescence reagent (Amersham, RPN2209) were used to
visualize protein bands.
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Quantification and statistical analysis
Statistics were performed in GraphPad Prism v8.3.0. For the cell size differences in confocal
images and RT-qPCR, pairwise comparisons were performed with the Mann–Whitney U test (twotailed) or unpaired Student’s t test. A value of P < 0.05 was considered to be statistically significant.
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Chapter 4: Conclusions and Future
Directions
4.1 Conclusion
A history of urinary tract infection (UTI), particularly in childhood, is a significant risk factor for
developing recurrent UTI (rUTI) as an adult, but the mechanisms behind this were previously not
well understood. Despite the importance of prior UTI history, this risk factor has rarely been
incorporated into animal models of this disease. Rather, concepts of UTI pathogenesis and host
determinants of rUTI has largely come from studies of naïve mice with no prior UTI history. To
better assess the sequelae due to an acute UTI and the effect of infection history on subsequent
infections, our lab has previously developed a mouse model of rUTI and found that an initial
chronic UTI precipitates long-term bladder remodeling and alters susceptibility to secondary
infections.
One of the distinguishing features of my research is the establishment of primary urothelial
cell lines from mice with a prior history of infection. Here, I specifically examined the role of
epithelial stem cells in bladder remodeling after an initial UTI. Using a primary epithelial stem
cell culture system, I found that bladder epithelial cells isolated and cultured from mice with
different UTI histories recapitulated the remodeling phenotypes observed in vivo when
differentiated on Transwells, indicating that the bladder epithelial stem cells retained the memory
of a prior infection. RNA-seq and ATAC-seq (chromatin structure mapping) showed that
epigenetic alterations in differentiation and programmed cell death (PCD) pathways were present
in the cell lines isolated from mice with a history of UTI, but that these changes differed with
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disease outcome. Specifically, I found that Sensitized mice demonstrated trained immunity against
UTI driven by enhanced Caspase 1-mediated inflammatory cell death accompanied by increased
Casp1 promoter accessibility.

The discovery that bacterial infection-induced epigenetic alterations in epithelial stem cells
determine the future susceptibility to an infectious disease may translate to other epithelial
infections in which relapse or recurrence is common, such as recurrent ear infections, recurrent
skin and soft tissue infections, and recurrent bacterial vaginosis. Thus, this work may ultimately
result in new therapeutic strategies aimed at reversing epigenetic driven changes in mucosal
surfaces that predispose to disease. In addition, my model of primary cell culture and differentiated
urothelium specifically represent a significant advance in the study of bladder mucosal responses
and has great potential for translation into human clinical studies.

4.2 Future Directions
I have established the culture system for differentiated urothelia using primary urothelial cells
isolated from single mouse bladder, but further optimization is required to achieve terminal
differentiation of superficial facet cells that can support IBC formation. The technique also can be
applied to patient specialized studies by isolating and culturing primary urothelial cells from
patient biopsy specimens. Using RNA-seq and ATAC-seq of USCs and differentiated urothelia of
Naïve, Resolved and Sensitized mice, I have shown how the Resolved and Sensitized urothelia are
differentially reprogrammed. Especially, I have uncovered Caspase 1-mediated protective
response in Sensitized urothelia. However, there are still many outstanding questions we can ask
based on the findings of differentially expressed genes and differentially enriched pathways
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between Resolved and Sensitized urothelia. I would like to introduce some of future research
directions which could improve our understanding of epithelial-intrinsic trained immunity after
UPEC infection.

4.2.1 Establishment of human urothelial cell lines using patient biopsies
As described above, one of the advantages of my primary urothelial culture system is that it can
establish cell lines from patient biopsy specimens. This would provide an in vitro system to pursue
personalized studies on patients with different genetic backgrounds and infection histories, which
potentially affect their susceptibility to recurrent infection. After isolating urothelial cells from
patient biopsies and culturing primary urothelial cells, patient-derived cells can be functionally
assessed by immunofluorescence, RT-qPCR, and cytokine expression profiling to determine if the
patient has the same remodeling marks that we found in mouse urothelial cells. Eventually,
differentiated urothelium originating from patients can be used for the development of clinical
studies to test personalized vaccines and other therapeutics.
Using this primary cell culture technique, I have isolated and passaged ureter epithelial
cells from patient biopsy specimens and cultured them on the Transwell until differentiation (Fig.
1). I have tested both bladder and ureter biopsy specimens, however bladder biopsy specimens did
not include enough epithelial cells to successfully culture primary epithelial stem cells.
Differentiated human ureter epithelium has many morphological similarities with mouse primary
urothelium including hexagonal superficial cells and surface expression of CK20 (Fig. 1). If
primary urothelial cell lines can be established from patients with only one prior UTI, patients with
multiple rUTIs, and patients with no history of UTI, those cell lines can be used to investigate the
genetic and epigenetic differences between groups.
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4.2.2 Further differentiation of the primary urothelium is required for the
formation of IBCs
Internalized UPEC bacteria escape into the cytoplasm and rapidly multiply resulting in the
maturation of IBCs, while protected from the mounting immune response and antibiotics (1-6).
However, UPEC infection in cell culture systems has not successfully reproduced IBC formation,
resulting in bacteria being trapped within Lamp1+ endosomes (7). Some of the cell culture systems
were able to facilitate intracellular bacterial replication in vitro in the presence of pharmacological
and genetic manipulations to disrupt actin cytoskeletal structures and signaling pathways (7-9). I
hypothesized that IBC formation in vitro would be possible in our primary urothelial cell cultures,
which appear to fully differentiate into urothelium. I cultured and differentiated primary
urothelium on Transwells for 2-3 weeks until it reached the maximum TER, then infected them
with UTI89 at MOI 50 for 24 hours to test if UTI89 can replicate intracellularly and form IBCs.
As shown in Chapter 2, UTI89 were capable of being internalized into the superficial urothelial
cells at 4 hpi. However, I did not observe any IBC formation in the infected differentiated
urothelium at 24 hpi. F-actin and Lamp1 positive vesicles were observed inside the superficial
urothelial cells at 24 hpi (Fig. 2A-B). This indicates that intracellular bacteria might be digested
inside Lamp1+ vesicles instead of escaping Lamp1+ endosome, replicating in cytoplasm, and
forming IBCs.
Unlike superficial facet cells allowing the formation of IBCs in cytoplasmic niche, our in
vitro differentiated superficial cells digested intracellular bacteria, which is more like the
characteristics of intermediate urothelial cells. Overall, differentiated urothelium, which has many
similarities with terminally differentiated superficial facet cells such as its unique morphology and
the expression of terminal differentiation markers is a good in vitro model for the study of bacterial
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adherence and invasion into the urothelial cells. The superficial cells of our differentiated
urothelium might need physical cues, for instance contact with non-epithelial cells or specific
substratum or stretching, which occurs during filling and emptying of the bladder in vivo, to fully
undergo changes in actin cytoskeleton needed to fully support IBC formation.

4.2.3 Further optimization for full differentiation of urothelium on Transwell
Additional optimization of culture system will be required for terminal differentiation and
functional characteristics of superficial facet cells in vitro to support IBC formation. The first thing
I can test is actin cytoskeleton disruptors, which have been known to increase bacterial intracellular
replication, to see if the disruption of actin cytoskeleton facilitates IBC formation in vitro. Filipin
is a cholesterol-binding agent often used to disrupt lipid rafts, and it has been found that it increases
uropathogen’s intracellular replication but does not affect invasion (7). Another cholesterolmodifying drug, methyl-beta-cyclodextrin (MbCD), is also known for disrupting actin
cytoskeleton and consequently decreases uropathogen’s invasion but does not affect its
intracellular proliferation (7, 9). Cytochalasin D and jasplakinolide are both known for increasing
intracellular growth of UTI89 in vitro, on the facilitation of IBC formation (8). While cytochalasin
D binds the barbed ends of F-actin and thus prevents actin filament elongation, jasplakinolide
competes with the actin-stabilizing phallotoxin phalloidin for binding sites on F-actin which
stabilizes or disrupts the actin cytoskeleton depending on the cell type (10). These direct and
indirect disruptors of actin cytoskeleton organization might facilitate IBC formation in the
differentiated urothelium. Additionally, mechanical properties of tissue environment are also
known to play an important role in regulating cell proliferation and differentiation as dynamics in
cytoskeletal organization affects mechanical input signals that cells get via changes in tension at
cell-cell adhesions and cell-extracellular matrix (ECM) adhesions (11-13). Therefore, culturing
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the primary urothelial cells on low stiffness scaffold mimicking urothelium environment in vivo
might facilitate terminal differentiation of urothelium in vitro.

4.2.4 Chromatin modifiers that contribute to urothelial epigenetic remodeling
upon UPEC infection
Using ATAC-seq, I found that urothelial stem cells have differential chromatin remodeling
dependent on infection histories. Chromatin remodeling is primarily accomplished through two
main mechanisms: histone modification and DNA methylation. Epigenetic “writers” are a group
of enzymes that introduce various chemical modifications to histones and DNA. Further
investigation into these epigenetic writers could shed light on how bacterial infection-mediated
inflammation facilitates initial chromatin remodeling. These enzymes include Enhancer of Zeste
Homolog 2 (Ezh2), which is a component of the polycomb repressor complex 2 (PRC2) that
trimethylates H3 lysine 27, and DNA methyltransferases (DNMTs), which methylate CpG regions
of DNA. Both Ezh2 and DNMTs have been implicated in the bladder’s response to UPEC infection
(14, 15).
Interestingly, I found that HOTAIR (including PRC2 complex) and DNA methylation
pathway-associated genes are differentially expressed in Resolved compared to Sensitized
differentiated urothelia (Fig. 3A-B), suggesting that Resolved and Sensitized urothelial cells were
differentially affected by epigenetic modifiers. HOTAIR is a lncRNA that binds to the PRC2
complex which makes epigenetic marks on chromatin in response to infection. Ezh2 showed
greater expression in Resolved differentiated urothelia relative to Sensitized and Naïve
differentiated urothelia. Thus, future studies could look at identifying differences in DNA
methylation and histone modification between our USC lines and test the ability of Ezh2 and
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DNMT inhibitors to alter remodeling of USCs and the subsequent susceptibility/response to UPEC
challenge in vitro and in vivo. Understanding how epigenetic remodeling occurs during the
infection and healing processes could potentially lead to therapeutic strategies to prevent and/or
reverse the sensitization of the urothelium in women who suffer from frequent rUTI.
In order to identify what types of chromatin modifications the urothelial stem cells undergo
after an initial UPEC infection, genome-wide screening of histone modification and DNA
methylation in USCs from Naïve, Resolved and Sensitized mice can be performed. Differences in
histone modification can be assessed by ChIP-seq using antibodies against five histone marks: H3
lysine 4 trimethylation, H3 lysine 4 monomethylation, H3 lysine 36 trimethylation, H3 lysine 27
trimethylation, and H3 lysine 9 trimethylation, which are associated with promoter, enhancer,
transcribed, Polycomb repression, and heterochromatin regions, respectively (16). Differences in
DNA methylation can be assayed by whole genome bisulfite sequencing (17). In conjunction with
my ATAC-seq and RNA-seq datasets, these studies will reveal correlations between specific
histone modifications and DNA methylation sites, chromatin accessibility and/or transcriptional
changes globally in the USCs.
USCs can be treated either with a DNA methylation inhibitor cocktail consisting of 5azacytidine and zebularine or an Ezh1/2 inhibitor, UNC1999, and determine if treatment alters
urothelial remodeling morphology and/or expression of immune sensor genes such as Naip2/5/6,
Casp1 and Gsdmc2/3 relative to vehicle-treated cultures. For in vivo studies, mouse models of
rUTI can be utilized to determine whether such treatment alters bladder remodeling and
susceptibility to rUTI. 8 week old female C3H/HeN mice could be treated with zebularine or
UNC1999 or vehicle, each administered by oral gavage, starting 1 hour prior to either infection
with 108 cfu or mock-infection with PBS. After 4 weeks of infection and 1 week of antibiotic
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therapy, it will be assessed how the loss of CpG and H3K27me3 methylation affects disease
outcome, urothelial remodeling phenotypes, and bladder pathophysiology using urine titers during
the 4 weeks of infection, primary USC isolation and culture, and bladder histopathology,
respectively. In addition, these mice could be challenge infected with 107 CFU UTI89 for 24 hours
and the severity of infection assayed by evaluating urine titer, bladder weights (measure of edema),
histopathology, bacterial burdens in the bladder and kidney tissue, and bladder cytokine
production. Once the effects of Ezh2 inhibitor or DNA methylase inhibitor on epigenetic
remodeling are demonstrated, further mouse studies can be performed to determine whether these
inhibitor treatments will reverse the epigenetic remodeling phenotypes described above.

4.2.5 Impact of differential epigenetic remodeling on programmed cell death
(PCD) in Resolved and Sensitized mice
My research shows that genes associated with PCD pathways are differentially regulated in
Resolved and Sensitized differentiated urothelia. Pyroptotic cell death associated genes, including
Aim2, Casp1, and Gsdmc2/3, were more transcribed in Sensitized differentiated urothelia in
agreement with previous studies showing upregulated protein expression in Sensitized bladder
compared to Resolved bladders upon UPEC infection (18). In contrast, apoptosis and necroptosisrelated genes showed greater expression in Resolved differentiated urothelia, suggesting
Sensitized and Resolved urothelial cells have different PCD mechanisms during UPEC infection.
In addition, ATAC-seq analysis demonstrates that the Casp1 promoter locus was accessible in
Sensitized USCs, but closed in Resolved and Naïve USCs, which was accompanied by induction
of Casp1 gene expression in

Sensitized

differentiated urothelium, independent

of

UTI89

infection. Further studies are needed to understand how these differences in epigenetic remodeling
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on PCD pathways affect urothelial remodeling phenotypes and immune response to secondary
infections.

We have previously found that IBC formation and clearance patterns are different in
Resolved and Sensitized mouse bladders upon secondary UPEC infection, which may be related
to their differential epigenetic remodeling on PCD associated genes. The bladders of Sensitized
mice do not support IBC formation. At 24 hours, these mice either have severe infection or are
resolving their infection (19). In contrast, the bladders of Resolved mice do support early IBC
formation, but rapidly eliminate these intracellular bacteria by selective exfoliation of IBCcontaining cells (19). I hypothesize that trained immunity in the form of urothelial-intrinsic
enhanced PCD pathway activation mediates these protective responses, but that the specific
pathways utilized differ between Resolved and Sensitized bladders. For example, gasdermins are
the terminal effectors of pyroptotic cell death. Upon activation, the N-terminal domain of
gasdermins insert into the cell membrane causing pore formation, potassium efflux, and pyroptotic
cell lysis (20). Gasdermin C was recently found to be activated by Caspase 8 to initiate pyroptosis
in response to TNFα in mammary carcinoma cells (21). The gsdmc2 and gsdmc3 genes are the
most highly expressed gasdermin genes in our cultured urothelia, regardless of disease history. It
can be investigated how inhibition/deletion of PCD components including Caspase 1 and
Gsdmc2/3 affect urothelial cell death, inflammation, and disease outcomes in Naïve, Resolved and
Sensitized urothelial cells. Cell death and exfoliation will be assessed by lactate dehydrogenase
(LDH) assay, TUNEL staining for apoptosis, and confocal microscopy. These experiments will
determine whether Naïve, Resolved, and Sensitized urothelial cells have different PCD response
upon challenge UPEC infection and how these different PCD responses affect the outcomes of
challenge infection.
112

4.2.6 Investigation of COX-2-dependent inflammation in C3H/HeN mice using
primary urothelial cells
Our lab has previously found that the severity of COX-2-mediated inflammatory response and
neutrophil transmigration at 24 hpi determins infection outcomes in Juvenile Naïve C3H/HeN
mice (18, 22). Furthermore, COX-2-dependent bladder inflammation triggers Sensitized mice to
develop rUTI upon a subsequent challenge infection (23). During convalescence, UTI history did
not influence the expression of the COX-2 gene, Ptgs2, which was minimal in the absence of
bacterial challenge. However, following challenge infection, Ptgs2 was induced in Naïve and
Sensitized mice but was not expressed in Resolved mice at 24 hpi. Thus, acute mucosal response
not only determines the outcome of infection, but also determines susceptibility to subsequent
challenge infections. COX-2 inhibition in juvenile C3H/HeN mice preserves the exfoliation and
neutrophil recruitment responses but moderates urothelial transmigration by neutrophils and
prevents mucosal wounding (24). As a result, bacterial clearance during acute infection is
enhanced with COX-2 inhibition and most mice resolve their infection. This effect was magnified
in the Sensitized mice, as these mice have some degree of adaptive immunity that comes forward
in the absence of COX-2 dependent inflammation.
COX-2 was expressed in both urothelial cells and neutrophils at 24 hpi and moderation of
neutrophil recruitment or direct partial depletion of neutrophils also prevents mucosal wounding
and chronic cystitis, directly implicating neutrophils in the pathogenesis of severe acute infection.
However, the presence of robust urothelial COX-2 expression strongly correlates with severe
inflammation. Urothelial damage by neutrophils is primarily mediated by free radicals and
oxidative/nitrosative stress, and oxidative stress is a potent inducer of COX-2 expression (25).
Quantitative proteomic analysis of urothelial cells isolated from convalescent mice showed that
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the expression of Vanin 1, which exacerbates inflammation during conditions of oxidative stress,
was increased, and the mu class of cytosolic glutathione S-transferases, which are critical for
neutralizing products of oxidative stress, were decreased (24). This suggests that Sensitized
urothelia are highly sensitive to oxidative stress due to altered expression of these genes. I
hypothesize that oxidative stress in the urothelium exacerbates COX-2 expression leading to
severe inflammation upon challenge infection. The interplay of COX-2 expression and oxidative
stress in urothelial and immune cells during primary urothelial infection can be investigated by
measuring pro-inflammatory cytokine and prostanoid production. It would be interesting to
investigate the different roles of urothelial and immune cell-mediated COX-2-dependent
inflammation on bladder mucosal defense. If the presence of oxidative stress is important or
required for COX-2-dependent inflammation, this may be another therapeutic target to prevent
and/or treat rUTIs.
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4.3 Figures

CK20 F-actin DAPI
Fig. 1. Primary human ureter epithelial cells differentiated on Transwell in vitro. Primary
epithelial cells isolated from human ureter biopsy were expanded by spheroidal culture in matrigel
with 50% CM as described above. 3-4x105 cells were then seeded onto the Transwell membrane
and cultured in 50% CM for 3-5 days then cultured in 5% CM for 2-3 weeks until full
differentiation. Differentiated epithelium on the Transwells were fixed and confocal stained for Factin, the terminal differentiation marker CK20, and nuclei (DAPI).
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Fig. 2. Differentiated urothelium appears to digest intracellular bacteria within Lamp1+
vacuoles at 24 hpi. Differentiated urothelia were infected with UTI89 at MOI 50 for 24 hours,
then processed for confocal staining. (A) UTI89 infected differentiated urothelia at 24 hpi were
immunostained for F-actin (red), E. coli (green), and nuclei (blue) or (B) immunostained for
Lamp1 (red), E. coli (green), and nuclei (blue). The colocalization of E. coli (green) and F-actin
(red) staining indicates intracellular bacteria or invading bacteria and the colocalization of E. coli
(green) and Lamp1 (red) indicates intracellular bacteria trapped within Lamp1+ endosome.
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Fig. 3. Chromatin remodeling associated genes were differentially expressed in Naïve,
Resolved, and Sensitized differentiated urothelia independent to UTI89 infection. Differential
expression of (A) HOTAIR and (B) DNA methylation associated genes are indicated as heatmap.
RNA-seq data of differentiated urothelia at 2 hpi with either PBS or UTI89. Each square is
technical replicate Transwell of one Naïve, Resolved, and Sensitized cell line. Z-score are
calculated across all samples for genes that are significantly differentially expressed between
Resolved-PBS and Sensitized-PBS cell lines (FDR <0.05).
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